TW201927752A - Carbazole oxime ester derivative compounds and photopolymerization initiator and photosensitive composition containing the same - Google Patents

Carbazole oxime ester derivative compounds and photopolymerization initiator and photosensitive composition containing the same Download PDF

Info

Publication number
TW201927752A
TW201927752A TW107144135A TW107144135A TW201927752A TW 201927752 A TW201927752 A TW 201927752A TW 107144135 A TW107144135 A TW 107144135A TW 107144135 A TW107144135 A TW 107144135A TW 201927752 A TW201927752 A TW 201927752A
Authority
TW
Taiwan
Prior art keywords
compound
photosensitive composition
group
meth
alkyl
Prior art date
Application number
TW107144135A
Other languages
Chinese (zh)
Other versions
TWI703129B (en
Inventor
李元重
吳泉林
李得洛
辛承林
全根
申鍾一
安慶龍
朴活基
吳柔珍
Original Assignee
韓商三養股份有限公司
韓國化學研究院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 韓商三養股份有限公司, 韓國化學研究院 filed Critical 韓商三養股份有限公司
Publication of TW201927752A publication Critical patent/TW201927752A/en
Application granted granted Critical
Publication of TWI703129B publication Critical patent/TWI703129B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/028Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
    • G03F7/031Organic compounds not covered by group G03F7/029

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Materials For Photolithography (AREA)
  • Indole Compounds (AREA)
  • Optical Filters (AREA)
  • Polymerisation Methods In General (AREA)

Abstract

The present disclosure relates to a carbazole oxime ester derivative compound represented by Chemical Formula 1 or Chemical Formula 2 and a photopolymerization initiator and a photosensitive composition containing the same. In Chemical Formulas 1 and 2, A and R1-R4 are the same as defined in the detailed description.

Description

咔唑肟酯衍生化合物以及含有其的光聚合起始劑及感光性組成物Oxazolium ester-derived compound, photopolymerization initiator containing the same, and photosensitive composition

本揭示案是有關一種咔唑肟酯衍生化合物以及含有其的光聚合起始劑及感光性組成物,更具體而言是有關一種咔唑肟酯衍生化合物以及含有其的光聚合起始劑及感光性組成物,該咔唑肟酯衍生化合物具有優異的感度、耐熱性、耐光性、耐化學藥品性及硬化性。The present disclosure relates to an oxazolidine derivative-derived compound, and a photopolymerization initiator and photosensitive composition therewith, and more particularly to an oxazolidin ester-derived compound and a photopolymerization initiator containing the same The photosensitive composition, the oxazolidine derivative-derived compound has excellent sensitivity, heat resistance, light resistance, chemical resistance, and hardenability.

一般而言,苯乙酮衍生物、二苯甲酮衍生物、三嗪衍生物、聯咪唑衍生物、醯基膦氧化物衍生物、肟酯衍生物等已作為光聚合起始劑來用於感光性組成物中。此等中,肟酯衍生物在下述點是有利的:該肟酯衍生物會藉由吸收紫外光而幾乎無色;顯示高自由基產生效率;與感光性組成物之其它成分之間之相容性優異;及安定性優異。然而,先前已開發出之肟酯衍生化合物在下述點有問題:該肟酯衍生化合物之光起始效率低、在圖案暴露處理期間感度低以至於應增加曝光或使用量,結果產量減少。In general, acetophenone derivatives, benzophenone derivatives, triazine derivatives, biimidazole derivatives, mercaptophosphine oxide derivatives, oxime ester derivatives, etc. have been used as photopolymerization initiators. In the photosensitive composition. Among these, the oxime ester derivative is advantageous in that the oxime ester derivative is almost colorless by absorbing ultraviolet light; exhibits high radical generation efficiency; and compatibility with other components of the photosensitive composition. Excellent sex; and excellent stability. However, the oxime ester-derived compound which has been previously developed has a problem in that the oxime ester-derived compound has a low light-initiating efficiency, and the sensitivity is low during the pattern exposure treatment so that the exposure or the amount of use should be increased, with the result that the yield is decreased.

因此,開發具有優異的感光性之光聚合起始劑能夠節省成本,其是因為即使小量的光聚合起始劑仍能夠達到充分的感度,且能夠提高生產性,其是因為感度優異以至於能夠減少曝光。Therefore, development of a photopolymerization initiator having excellent photosensitivity can save cost because even a small amount of photopolymerization initiator can achieve sufficient sensitivity and productivity can be improved because the sensitivity is excellent. Can reduce exposure.

然而,當使用習知的光聚合起始劑來形成圖案時,在形成圖案之暴露處理中感度低以至於需要增加光聚合起始劑之量或暴露劑量,結果產生下述缺點:遮罩在暴露處理期間受到污染、及在高溫交聯期間光聚合起始劑分解後產生之副產物降低產率,而暴露處理時間隨著增加暴露劑量而增加以至於有生產量降低之問題,因此,已努力解決該問題。
[先前技術文獻]
(專利文獻)
However, when a conventional photopolymerization initiator is used to form a pattern, the sensitivity is so low in the exposure treatment for pattern formation that it is necessary to increase the amount or exposure dose of the photopolymerization initiator, resulting in the following disadvantages: Contamination during exposure treatment and by-products produced by decomposition of the photopolymerization initiator during high temperature crosslinking reduce the yield, and the exposure treatment time increases with increasing exposure dose so that there is a problem of reduced production, therefore, Try to solve the problem.
[Previous Technical Literature]
(Patent Literature)

專利文獻1:國際專利公開第WO02/100903 (2002. 12. 19)。
專利文獻2:日本專利公開第2005-025169 (2005. 01. 27)。
專利文獻3:國際專利公開第WO07/071497 (2007. 06. 28)。
專利文獻4:韓國專利公開第2013-0124215 (2013. 11. 13)。
專利文獻5:韓國專利公開第2013-0115272 (2013. 10. 21)
Patent Document 1: International Patent Publication No. WO 02/100903 (2002. 12. 19).
Patent Document 2: Japanese Patent Laid-Open Publication No. 2005-025169 (2005. 01. 27).
Patent Document 3: International Patent Publication No. WO07/071497 (2007. 06.28).
Patent Document 4: Korean Patent Publication No. 2013-0124215 (2013. 11. 13).
Patent Document 5: Korean Patent Publication No. 2013-0115272 (2013. 10. 21)

[發明所欲解決之問題]
本揭示案是有關提供一種咔唑肟酯衍生化合物以及含有其的光聚合起始劑及感光性組成物,該咔唑肟酯衍生化合物具有優異的感度、耐熱性、耐化學藥品性及硬化性。
[The problem that the invention wants to solve]
The present disclosure relates to an oxime oxime ester-derived compound having a sensitivity, heat resistance, chemical resistance, and sclerosing property, and a photopolymerization initiator containing the same, and a photosensitive composition containing the same. .

本揭示案亦有關提供一種模製品,其含有該感光性組成物之硬化產物。The present disclosure also relates to providing a molded article containing a hardened product of the photosensitive composition.

本揭示案亦有關提供一種顯示裝置,其含有該模製品。
[解決問題之技術手段]
The present disclosure also relates to providing a display device comprising the molded article.
[Technical means to solve the problem]

一態樣中,本揭示案提供如下所述之實施形態之範例之咔唑肟酯衍生化合物。In one aspect, the present disclosure provides an oxazolidinate derivative compound exemplified by the embodiments described below.

第一實施形態之範例是有關一種咔唑肟酯衍生化合物,其是如化學式1或化學式2所示:
<化學式1>     <化學式2>

化學式1及2中,
A為氧或硫;
R1 及R4 分別獨立地為(C1 ~C20 )烷基;
R2 為(C1 ~C20 )烷基、(C6 ~C20 )芳基、(C1 ~C20 )烷氧基、(C6 ~C20 )芳基(C1 ~C20 )烷基、羥基(C1 ~C20 )烷基、羥基(C1 ~C20 )烷氧基(C1 ~C20 )烷基或(C3 ~C20 )環烷基;且
R3 為(C1 ~C20 )烷基、(C6 ~C20 )芳基、(C6 ~C20 )芳基(C1 ~C20 )烷基、(C3 ~C20 )環烷基或(C3 ~C20 )環烷基(C1 ~C20 )烷基。
An example of the first embodiment relates to an oxazolidine derivative-derived compound which is represented by Chemical Formula 1 or Chemical Formula 2:
<Chemical Formula 1><Chemical Formula 2>

In Chemical Formulas 1 and 2,
A is oxygen or sulfur;
R 1 and R 4 are each independently (C 1 - C 20 ) alkyl;
R 2 is (C 1 - C 20 ) alkyl, (C 6 - C 20 ) aryl, (C 1 - C 20 ) alkoxy, (C 6 - C 20 ) aryl (C 1 - C 20 ) An alkyl group, a hydroxyl group (C 1 - C 20 ) alkyl group, a hydroxyl group (C 1 - C 20 ) alkoxy group (C 1 - C 20 ) alkyl group or a (C 3 - C 20 ) cycloalkyl group;
R 3 is (C 1 - C 20 ) alkyl, (C 6 - C 20 ) aryl, (C 6 - C 20 ) aryl (C 1 - C 20 ) alkyl, (C 3 - C 20 ) ring An alkyl group or a (C 3 - C 20 ) cycloalkyl (C 1 - C 20 ) alkyl group.

第二實施形態之範例是有關如第一實施形態之範例所述之咔唑肟酯衍生化合物,其中,
R1 及R4 分別獨立地為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基或異己基;
R2 為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、異己基、正辛基、正癸基、異癸基、正十二烷基、環戊基、環己基、苯基、苯甲基、萘基、聯苯、聯三苯、蒽基、茚基、菲基、甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、三級丁氧基、羥基甲基、羥基乙基、羥基正丙基、羥基正丁基、羥基異丁基、羥基正戊基、羥基異戊基、羥基正己基、羥基異己基、羥基甲氧基甲基、羥基甲氧基乙基、羥基甲氧基丙基、羥基甲氧基丁基、羥基乙氧基甲基、羥基乙氧基乙基、羥基乙氧基丙基、羥基乙氧基丁基、羥基乙氧基戊基或羥基乙氧基己基;且
R3 為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、異己基、環戊基、環己基或苯基。
An example of the second embodiment relates to an oxazolyl ester derivative compound as described in the example of the first embodiment, wherein
R 1 and R 4 are each independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl or isohexyl;
R 2 is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, isohexyl, n-octyl, n-decene Base, isodecyl, n-dodecyl, cyclopentyl, cyclohexyl, phenyl, benzyl, naphthyl, biphenyl, terphenyl, anthracenyl, fluorenyl, phenanthryl, methoxy, B Oxyl, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, hydroxymethyl, hydroxyethyl, hydroxy-n-propyl, hydroxy-n-butyl, hydroxy-isobutyl Base, hydroxy-n-pentyl, hydroxyisopentyl, hydroxy-n-hexyl, hydroxyisohexyl, hydroxymethoxymethyl, hydroxymethoxyethyl, hydroxymethoxypropyl, hydroxymethoxybutyl, hydroxyethyl Oxymethyl, hydroxyethoxyethyl, hydroxyethoxypropyl, hydroxyethoxybutyl, hydroxyethoxypentyl or hydroxyethoxyhexyl;
R 3 is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, isohexyl, cyclopentyl, cyclohexyl Or phenyl.

第三實施形態之範例是有關第一實施形態之範例或第二實施形態之範例,其中,該咔唑肟酯衍生化合物為從化學式3-1~3-18所示之化合物之中選出之咔唑肟酯衍生化合物:
<化學式3-1~3-18>





An example of the third embodiment is an example of the first embodiment or an example of the second embodiment, wherein the oxazolyl ester derivative compound is selected from the compounds represented by Chemical Formulas 3-1 to 3-18. Azole ester derived compound:
<Chemical Formula 3-1 to 3-18>





.

另一態樣中,本揭示案提供如下所述之實施形態之範例之光聚合起始劑。In another aspect, the present disclosure provides a photopolymerization initiator as exemplified in the embodiments described below.

第四實施形態之範例是有關一種光聚合起始劑,其含有第一實施形態之範例至第三實施形態之範例中任一種所述之咔唑肟酯衍生化合物。An example of the fourth embodiment relates to a photopolymerization initiator comprising the carbazolyl ester derivative compound according to any one of the examples of the first embodiment to the third embodiment.

另一態樣中,本揭示案提供如下所述之實施形態之範例之感光性組成物。In another aspect, the present disclosure provides a photosensitive composition of an example of the embodiment described below.

第五實施形態之範例是有關一種感光性組成物,其含有:
(a)一鹼可溶性樹脂;
(b)一聚合性化合物,其具有一乙烯性不飽和鍵;及
(c)一光聚合起始劑,其含有第一實施形態之範例至第三實施形態之範例中任一種所述之咔唑肟酯衍生化合物。
An example of the fifth embodiment relates to a photosensitive composition comprising:
(a) an alkali soluble resin;
(b) a polymerizable compound having an ethylenically unsaturated bond;
(c) A photopolymerization initiator comprising the oxazolidinate derivative compound according to any one of the examples of the first embodiment to the third embodiment.

第六實施形態之範例是有關如第五實施形態之範例所述之感光性組成物,其中,以該感光性組成物100 wt%為基準,該咔唑肟酯衍生化合物之含量為0.01~10 wt%。An example of the sixth embodiment is the photosensitive composition according to the example of the fifth embodiment, wherein the content of the oxazolidine derivative-derived compound is 0.01 to 10 based on 100% by weight of the photosensitive composition. Wt%.

第七實施形態之範例是有關如第五實施形態之範例或第六實施形態之範例所述之感光性組成物,其中,該光聚合起始劑復含有從由一噻噸酮(thioxanthone)基礎的化合物、一醯基膦氧化物基礎的化合物、一苯乙酮基礎的化合物、一聯咪唑基礎的化合物、一三嗪基礎的化合物、一O-醯基肟酯基礎的化合物或一硫醇基礎的化合物所組成之群組中選出之一或更多種。An example of the seventh embodiment is the photosensitive composition according to the example of the fifth embodiment or the example of the sixth embodiment, wherein the photopolymerization initiator further comprises a base of thioxanthone a compound, a monophosphonium oxide based compound, a acetophenone based compound, a biimidazole based compound, a triazine based compound, an O-mercapto oxime based compound or a monothiol base One or more of the groups consisting of the compounds are selected.

第八實施形態之範例是有關如第五實施形態之範例至第七實施形態之範例中任一種所述之感光性組成物,其中,該感光性組成物復含有一著色材料。The photosensitive composition according to any one of the examples of the fifth embodiment to the seventh embodiment, wherein the photosensitive composition further comprises a coloring material.

另一態樣中,本揭示案提供如下所述之實施形態之範例之模製品、及含有其的顯示裝置。In another aspect, the present disclosure provides a molded article of an embodiment of the embodiment described below, and a display device including the same.

第九實施形態之範例是有關一種模製品,其含有第五實施形態之範例至第八實施形態之範例中任一種所述之感光性組成物之硬化產物。An example of the ninth embodiment relates to a molded article comprising a cured product of the photosensitive composition according to any one of the examples of the fifth embodiment to the eighth embodiment.

第十實施形態之範例是有關如第九實施形態之範例所述之模製品,其中,該模製品為一陣列平坦化膜、一絕緣膜、一濾色器、一柱狀間隔物、一黑色柱狀間隔物或一黑色矩陣。An example of the tenth embodiment is the molded article according to the example of the ninth embodiment, wherein the molded article is an array of planarizing film, an insulating film, a color filter, a column spacer, and a black Column spacers or a black matrix.

第十一實施形態之範例是有關一種顯示裝置,其含有第九實施形態之範例或第十實施形態之範例所述之模製品。
[功效]
An example of the eleventh embodiment relates to a display device comprising the molded article according to the example of the ninth embodiment or the example of the tenth embodiment.
[efficacy]

本揭示案之實施形態之範例之咔唑肟酯衍生化合物當作為感光性組成物之光聚合起始劑使用時,會顯示非常優異的感度,且亦顯示極佳的物理性質,例如膜殘留率、圖案安定性、耐熱性、耐化學藥劑性、柔軟度等。因此,能夠藉由使在薄膜電晶體液晶顯示器(TFT-LCD)製造過程中之曝光及後烤處理期間從光聚合起始劑發生之釋氣最小化來降低污染,且能夠使由其所產生之缺陷最小化。The oxazolidine derivative derivative which is an example of the embodiment of the present disclosure exhibits excellent sensitivity when used as a photopolymerization initiator of a photosensitive composition, and also exhibits excellent physical properties such as film residual ratio. , pattern stability, heat resistance, chemical resistance, softness, etc. Therefore, it is possible to reduce the contamination by minimizing the outgassing from the photopolymerization initiator during the exposure and post-baking treatment in the manufacturing process of the thin film transistor liquid crystal display (TFT-LCD), and to enable the generation thereof The defects are minimized.

以下,一面參照所附圖式,一面詳細敘述本揭示案之較佳的實施形態。在敘述之前,應理解,說明書及所附之申請專利範圍中所使用之用語不應被理解為受限於一般及辭典的意義,而是應以允許發明人適當地定義術語以獲得最佳解釋之原理為基礎依據符合本揭示案之技術態樣之意義及概念來解釋。Hereinafter, preferred embodiments of the present disclosure will be described in detail with reference to the accompanying drawings. Before the narrative, it should be understood that the terms used in the specification and the accompanying claims should not be construed as being limited to the meaning of the general and dictionary, but should be construed as allowing the inventor to define the terms appropriately for the best explanation. The principle is based on the meaning and concept of the technical aspects of the present disclosure.

因此,本文中提出之敘述僅是為了說明之目的之較佳例,並非旨在限制本揭示案之範圍,因此應理解,能夠在不脫離本揭示案之範圍之情形下使其為其它同等物及對其進行修改。Therefore, the descriptions of the present invention are intended to be illustrative only, and are not intended to limit the scope of the disclosure, and thus it is understood that other equivalents can be made without departing from the scope of the disclosure. And modify it.

本揭示案之一態樣之咔唑肟酯衍生化合物是如化學式1或2所示。
<化學式1>     <化學式2>

化學式1及2中,
A為氧或硫;
R1 及R4 分別獨立地為(C1 ~C20 )烷基;
R2 為(C1 ~C20 )烷基、(C6 ~C20 )芳基、(C1 ~C20 )烷氧基、(C6 ~C20 )芳基(C1 ~C20 )烷基、羥基(C1 ~C20 )烷基、羥基(C1 ~C20 )烷氧基(C1 ~C20 )烷基或(C3 ~C20 )環烷基;且
R3 為(C1 ~C20 )烷基、(C6 ~C20 )芳基、(C6 ~C20 )芳基(C1 ~C20 )烷基、(C3 ~C20 )環烷基或(C3 ~C20 )環烷基(C1 ~C20 )烷基。
The oxazolidinate-derived compound which is one aspect of the present disclosure is as shown in Chemical Formula 1 or 2.
<Chemical Formula 1><Chemical Formula 2>

In Chemical Formulas 1 and 2,
A is oxygen or sulfur;
R 1 and R 4 are each independently (C 1 - C 20 ) alkyl;
R 2 is (C 1 - C 20 ) alkyl, (C 6 - C 20 ) aryl, (C 1 - C 20 ) alkoxy, (C 6 - C 20 ) aryl (C 1 - C 20 ) An alkyl group, a hydroxyl group (C 1 - C 20 ) alkyl group, a hydroxyl group (C 1 - C 20 ) alkoxy group (C 1 - C 20 ) alkyl group or a (C 3 - C 20 ) cycloalkyl group;
R 3 is (C 1 - C 20 ) alkyl, (C 6 - C 20 ) aryl, (C 6 - C 20 ) aryl (C 1 - C 20 ) alkyl, (C 3 - C 20 ) ring An alkyl group or a (C 3 - C 20 ) cycloalkyl (C 1 - C 20 ) alkyl group.

本揭示案中,’烷基’、’烷氧基’及含有’烷基’部分之其它取代基包括直鏈或分枝之形式,且’環烷基’不僅包括單環且亦包括多環烴基。In the present disclosure, 'alkyl', 'alkoxy' and other substituents containing 'alkyl' moieties include straight-chain or branched forms, and 'cycloalkyl' includes not only monocyclic but also polycyclic Hydrocarbyl group.

並且,本揭示案中,’芳基’是指從芳香族烴藉由將一個氫去除來衍生出之有機自由基且包括單環或稠合環系統以及其中有複數個芳基經單鍵來連接而成之形式。Also, in the present disclosure, 'aryl' refers to an organic radical derived from the removal of a hydrogen by an aromatic hydrocarbon and includes a monocyclic or fused ring system and a plurality of aryl groups thereof via a single bond. Connected form.

並且,本揭示案中,’羥基烷基’是指OH-烷基,其中,羥基經與上述烷基鍵結,’羥基烷氧基烷基’是指羥基烷基-O-烷基,其中,烷氧基經與羥基烷基鍵結,且烯基是指含有經與烷基或芳基鍵結之酮之結構。Also, in the present disclosure, 'hydroxyalkyl group' means an OH-alkyl group in which a hydroxyl group is bonded to the above alkyl group, and 'hydroxyalkoxyalkyl group' means a hydroxyalkyl-O-alkyl group, wherein The alkoxy group is bonded to a hydroxyalkyl group, and the alkenyl group means a structure containing a ketone bonded to an alkyl group or an aryl group.

並且,本揭示案中,’芳基烷基’可例示如苯甲基等,’環烷基’可例示如:環丙基、環丁基、環戊基、環己基等,且’環烷基烷基’可例示如:環丙基甲基、環丁基甲基、環戊基甲基、環丙基乙基等。Further, in the present disclosure, 'arylalkyl' may be exemplified by benzyl or the like, and 'cycloalkyl' may, for example, be cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or the like, and 'cycloalkane' The alkyl group 'is exemplified by cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclopropylethyl and the like.

並且,本揭示案中,’(C1 ~C20 )烷基’是指具有1~20個碳之烷基。該烷基可具體地為(C1 ~C10 )烷基,更具體地為(C1 ~C6 )烷基。Further, in the present disclosure, '(C 1 - C 20 ) alkyl group' means an alkyl group having 1 to 20 carbons. The alkyl group may specifically be a (C 1 - C 10 ) alkyl group, more specifically a (C 1 - C 6 ) alkyl group.

‘(C6 ~C20 )芳基’是指具有6~20個碳之芳基。該芳基可具體地為(C6 ~C18 )芳基,更具體地為(C6 ~C12 )芳基。'(C 6 - C 20 ) aryl' means an aryl group having 6 to 20 carbons. The aryl group may specifically be a (C 6 - C 18 ) aryl group, more specifically a (C 6 - C 12 ) aryl group.

‘(C1 ~C20 )烷氧基’是指具有1~20個碳之烷氧基。該烷氧基可具體地為(C1 ~C10 )烷氧基,更具體地為(C1 ~C4 )烷基。'(C 1 - C 20 ) alkoxy' means an alkoxy group having 1 to 20 carbons. The alkoxy group may specifically be a (C 1 - C 10 ) alkoxy group, more specifically a (C 1 - C 4 ) alkyl group.

‘(C6 ~C20 )芳基(C1 ~C20 )烷基’是指一個氫經具有6~20個碳之芳基所取代之具有1~20個碳之烷基。可具體地為(C6 ~C18 )芳基(C1 ~C10 )烷基,更具體地為(C6 ~C18 )芳基(C1 ~C6 )烷基,再更具體地為(C6 ~C12 )芳基(C1 ~C6 )烷基。'(C 6 - C 20 ) aryl (C 1 - C 20 ) alkyl ' refers to an alkyl group having 1 to 20 carbons substituted with an aryl group having 6 to 20 carbons. It may specifically be (C 6 - C 18 ) aryl (C 1 - C 10 ) alkyl, more specifically (C 6 - C 18 ) aryl (C 1 - C 6 ) alkyl, and more particularly It is (C 6 - C 12 ) aryl (C 1 - C 6 ) alkyl.

‘羥基(C1 ~C20 )烷基’是指一個氫經羥基所取代之具有1~20個碳之烷基。可具體地為羥基(C1 ~C10 )烷基,更具體地為羥基(C1 ~C6 )烷基。'Hydroxy (C 1 - C 20 ) alkyl' means an alkyl group having 1 to 20 carbons in which a hydrogen is substituted by a hydroxyl group. It may specifically be a hydroxy (C 1 - C 10 ) alkyl group, more specifically a hydroxy (C 1 - C 6 ) alkyl group.

‘羥基(C1 ~C20 )烷氧基(C1 ~C20 )烷基’是指一個氫經具有1~20個碳之烷氧基所取代且該烷氧基之一個氫經羥基所取代之具有1~20個碳之烷基。可具體地為羥基(C1 ~C10 )烷氧基(C1 ~C10 )烷基,更具體地為羥基(C1 ~C4 )烷氧基(C1 ~C6 )烷基。'Hydroxy(C 1 -C 20 )alkoxy(C 1 -C 20 )alkyl' means that a hydrogen is substituted by an alkoxy group having from 1 to 20 carbons and one hydrogen of the alkoxy group is via a hydroxyl group Substituting an alkyl group having 1 to 20 carbons. It may specifically be a hydroxyl (C 1 - C 10 ) alkoxy (C 1 - C 10 ) alkyl group, more specifically a hydroxyl (C 1 - C 4 ) alkoxy (C 1 - C 6 ) alkyl group.

‘(C3 ~C20 )環烷基’是指具有3~20個碳之環烷基,可具體地為(C3 ~C10 )環烷基。'(C 3 - C 20 )cycloalkyl' means a cycloalkyl group having 3 to 20 carbons, and specifically may be a (C 3 - C 10 ) cycloalkyl group.

‘(C3 ~C20 )環烷基(C1 ~C20 )烷基’是指一個氫經具有3~20個碳之環烷基所取代之具有1~20個碳之烷基,且可具體地為(C3 ~C10 )環烷基(C1 ~C10 )烷基,更具體地為(C3 ~C6 )環烷基(C1 ~C6 )烷基。'(C 3 -C 20 )cycloalkyl(C 1 -C 20 )alkyl' means an alkyl group having 1 to 20 carbons substituted by a cycloalkyl group having 3 to 20 carbons, and It may specifically be (C 3 - C 10 ) cycloalkyl (C 1 - C 10 ) alkyl, more specifically (C 3 - C 6 ) cycloalkyl (C 1 - C 6 ) alkyl.

本揭示案之實施形態之範例中,化學式1及2中,
A可為氧或硫;
R1 及R4 可分別獨立地為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基或異己基;
R2 可為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、異己基、正辛基、正癸基、異癸基、正十二烷基、環戊基、環己基、苯基、苯甲基、萘基、聯苯、聯三苯、蒽基、茚基、菲基、甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、三級丁氧基、羥基甲基、羥基乙基、羥基正丙基、羥基正丁基、羥基異丁基、羥基正戊基、羥基異戊基、羥基正己基、羥基異己基、羥基甲氧基甲基、羥基甲氧基乙基、羥基甲氧基丙基、羥基甲氧基丁基、羥基乙氧基甲基、羥基乙氧基乙基、羥基乙氧基丙基、羥基乙氧基丁基、羥基乙氧基戊基或羥基乙氧基己基;且
R3 可為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、異己基、環戊基、環己基或苯基。
In the examples of the embodiments of the present disclosure, in Chemical Formulas 1 and 2,
A can be oxygen or sulfur;
R 1 and R 4 may each independently be methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl or isohexyl. ;
R 2 may be methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, isohexyl, n-octyl, positive Sulfhydryl, isodecyl, n-dodecyl, cyclopentyl, cyclohexyl, phenyl, benzyl, naphthyl, biphenyl, terphenyl, anthracenyl, fluorenyl, phenanthryl, methoxy, Ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, hydroxymethyl, hydroxyethyl, hydroxy-n-propyl, hydroxy-n-butyl, hydroxy Butyl, hydroxy-n-pentyl, hydroxyisopentyl, hydroxy-n-hexyl, hydroxyisohexyl, hydroxymethoxymethyl, hydroxymethoxyethyl, hydroxymethoxypropyl, hydroxymethoxybutyl, hydroxy Ethoxymethyl, hydroxyethoxyethyl, hydroxyethoxypropyl, hydroxyethoxybutyl, hydroxyethoxypentyl or hydroxyethoxyhexyl;
R 3 may be methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, isohexyl, cyclopentyl, ring Hexyl or phenyl.

更具體而言,化學式1及2中,
A可為氧或硫;
R1 及R4 可分別獨立地為甲基、乙基或正丙基;
R2 可為甲基、乙基、正丙基、異丙基、正丁基、正戊基、環己基、苯基或苯甲基;且
R3 可為甲基、乙基、正丙基或苯基。
More specifically, in Chemical Formulas 1 and 2,
A can be oxygen or sulfur;
R 1 and R 4 may each independently be a methyl group, an ethyl group or a n-propyl group;
R 2 may be methyl, ethyl, n-propyl, isopropyl, n-butyl, n-pentyl, cyclohexyl, phenyl or benzyl;
R 3 may be methyl, ethyl, n-propyl or phenyl.

本揭示案之實施形態之範例中,該咔唑肟酯衍生化合物可為從化學式3-1~3-18之化合物之中選出之化合物,但本揭示案並不限於該等化合物。
<化學式3-1~3-18>





In the examples of the embodiments of the present disclosure, the oxazolyl ester derivative compound may be a compound selected from the compounds of Chemical Formulas 3-1 to 3-18, but the present disclosure is not limited to the compounds.
<Chemical Formula 3-1 to 3-18>





.

本揭示案之化學式1或化學式2所示之咔唑肟酯衍生化合物可依據反應式1或2來製備,但不限於此。
[反應式1]

[反應式2]
The oxazolidinate derivative compound represented by Chemical Formula 1 or Chemical Formula 2 of the present disclosure can be produced according to Reaction Formula 1 or 2, but is not limited thereto.
[Reaction formula 1]

[Reaction formula 2]

反應式1或2中,A及R1 ~R4 與化學式1或2中之定義相同,且X為鹵素。In Reaction Formula 1 or 2, A and R 1 to R 4 are the same as defined in Chemical Formula 1 or 2, and X is a halogen.

本揭示案之另一態樣之光聚合起始劑含有化學式1或化學式2所示之咔唑肟酯衍生化合物之一或更多種。The photopolymerization initiator of another aspect of the present disclosure contains one or more of the oxazolidinate derivative compounds represented by Chemical Formula 1 or Chemical Formula 2.

本揭示案之另一態樣之感光性組成物含有:
(a)一鹼可溶性樹脂;
(b)一聚合性化合物,其具有一乙烯性不飽和鍵;及
(c)一光聚合起始劑,其含有從化學式1或2之咔唑肟酯衍生化合物之中選出之一或更多種。
Another aspect of the photosensitive composition of the present disclosure contains:
(a) an alkali soluble resin;
(b) a polymerizable compound having an ethylenically unsaturated bond;
(c) a photopolymerization initiator containing one or more selected from the group consisting of the oxazolidinate-derived compounds of Chemical Formula 1 or 2.

咔唑肟酯衍生化合物可作為光聚合起始劑來含有。The oxazolyl ester-derived compound can be contained as a photopolymerization initiator.

本揭示案之另一態樣之感光性組成物具有極佳的控制圖案特徵之能力及極佳的例如耐熱性、耐化學藥劑性等薄膜(thin-film)性質。以下,詳細敘述本揭示案之感光性組成物中可含有之成分。The photosensitive composition of another aspect of the present disclosure has excellent ability to control pattern characteristics and excellent thin-film properties such as heat resistance and chemical resistance. Hereinafter, the components which can be contained in the photosensitive composition of this publication are mentioned in detail.

本揭示案中,(甲基)丙烯醯基是意指丙烯醯基及/或甲基丙烯醯基,(甲基)丙烯酸酯是意指丙烯酸酯及/或甲基丙烯酸酯,且(甲基)丙烯酸是意指丙烯酸及/或甲基丙烯酸。In the present disclosure, (meth)acryl fluorenyl means propylene fluorenyl and/or methacryl fluorenyl, (meth) acrylate means acrylate and/or methacrylate, and (methyl Acrylic acid means acrylic acid and/or methacrylic acid.

[(a)鹼可溶性樹脂]
作為鹼可溶性樹脂,可使用丙烯酸系聚合物或側鏈具有不飽和丙烯酸鍵(acryl bond)之丙烯酸系聚合物。
[(a) alkali soluble resin]
As the alkali-soluble resin, an acrylic polymer or an acrylic polymer having an unsaturated acryl bond in its side chain can be used.

丙烯酸系聚合物是指丙烯酸系單體之聚合物(包括均聚物或共聚物)。單體之例子包括(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸丙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸戊酯、(甲基)丙烯酸己酯、(甲基)丙烯酸環己酯、(甲基)丙烯酸庚酯、(甲基)丙烯酸辛酯、(甲基)丙烯酸壬酯、(甲基)丙烯酸癸酯、(甲基)丙烯酸月桂酯、(甲基)丙烯酸十二烷酯、(甲基)丙烯酸十四烷酯、(甲基)丙烯酸十六烷酯、(甲基)丙烯酸異冰片酯、(甲基)丙烯酸金剛烷酯、(甲基)丙烯酸雙環戊烷酯、(甲基)丙烯酸雙環戊二烯酯、(甲基)丙烯酸苯甲酯、(甲基)丙烯酸2-甲氧基乙酯、(甲基)丙烯酸2-乙氧基乙酯、(甲基)丙烯酸、伊康酸、馬來酸、馬來酸酐、馬來酸單烷酯、伊康酸單烷酯、富馬酸單烷酯、(甲基)丙烯酸縮水甘油酯、(甲基)丙烯酸3,4-環氧基丁酯、(甲基)丙烯酸2,3-環氧基環己酯、(甲基)丙烯酸3,4-環氧基環己基甲酯、(甲基)丙烯酸3-甲基氧雜環丁烷-3-甲酯、(甲基)丙烯酸3-乙基氧雜環丁烷-3-甲酯、苯乙烯、α-甲基苯乙烯、乙醯氧基苯乙烯、N-甲基馬來醯亞胺、N-乙基馬來醯亞胺、N-丙基馬來醯亞胺、N-丁基馬來醯亞胺、N-環己基馬來醯亞胺、(甲基)丙烯醯胺、N-甲基(甲基)丙烯醯胺等,且該等可單獨使用或組合使用。The acrylic polymer refers to a polymer (including a homopolymer or a copolymer) of an acrylic monomer. Examples of the monomer include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, amyl (meth)acrylate, (meth)acrylic acid Hexyl ester, cyclohexyl (meth)acrylate, heptyl (meth)acrylate, octyl (meth)acrylate, decyl (meth)acrylate, decyl (meth)acrylate, laurel (meth)acrylate Ester, dodecyl (meth)acrylate, tetradecyl (meth)acrylate, hexadecyl (meth)acrylate, isobornyl (meth)acrylate, adamantyl (meth)acrylate, Dicyclopentanyl (meth)acrylate, dicyclopentadienyl (meth)acrylate, benzyl (meth)acrylate, 2-methoxyethyl (meth)acrylate, 2-(meth)acrylate Ethoxyethyl ester, (meth)acrylic acid, itaconic acid, maleic acid, maleic anhydride, monoalkyl maleate, monostannic acid, monoalkyl fumarate, (meth)acrylic acid Glycidyl ester, 3,4-epoxybutyl (meth)acrylate, 2,3-epoxycyclohexyl (meth)acrylate, 3,4-epoxycyclohexyl (meth)acrylate Ester, 3-methyloxetane (meth)acrylate 3-methyl ester, 3-ethyloxetane-3-methyl (meth)acrylate, styrene, α-methylstyrene, ethoxylated styrene, N-methyl maleate Imine, N-ethylmaleimide, N-propylmaleimide, N-butylmaleimide, N-cyclohexylmaleimide, (meth)acrylamide N-methyl(meth)acrylamide or the like, and these may be used singly or in combination.

並且,作為側鏈具有不飽和丙烯酸鍵之丙烯酸系聚合物之例子可使用如下:藉由將環氧樹脂加成在含有羧酸之丙烯酸系共聚物來獲得之共聚物;藉由在40~180℃將環氧樹脂加成在藉由含有羧酸之丙烯酸系單體及二或更多種單體及一單體之共聚來獲得之含有羧酸之丙烯酸系共聚物來獲得之黏合劑樹脂,該環氧樹脂為例如(甲基)丙烯酸縮水甘油酯、(甲基)丙烯酸3,4-環氧基丁酯、(甲基)丙烯酸2,3-環氧基環己酯、(甲基)丙烯酸3,4-環氧基環己基甲酯等,該含有羧酸之丙烯酸系單體為例如(甲基)丙烯酸、伊康酸、馬來酸、馬來酸單烷酯等,該二或更多種單體為例如例如(甲基)丙烯酸甲酯、(甲基)丙烯酸己酯等(甲基)丙烯酸烷酯等,該一單體為例如(甲基)丙烯酸環己酯、(甲基)丙烯酸異冰片酯、(甲基)丙烯酸金剛烷酯、(甲基)丙烯酸雙環戊烷酯、(甲基)丙烯酸雙環戊二烯酯、(甲基)丙烯酸苯甲酯、(甲基)丙烯酸2-甲氧基乙酯、(甲基)丙烯酸2-乙氧基乙酯、苯乙烯、α-甲基苯乙烯、乙醯氧基苯乙烯、N-甲基馬來醯亞胺、N-乙基馬來醯亞胺、N-丙基馬來醯亞胺、N-丁基馬來醯亞胺、N-環己基馬來醯亞胺、(甲基)丙烯醯胺、N-甲基(甲基)丙烯醯胺等。Further, as an example of the acrylic polymer having an unsaturated acrylic bond in its side chain, a copolymer obtained by adding an epoxy resin to an acrylic copolymer containing a carboxylic acid; by 40 to 180 °C is an epoxy resin obtained by adding an epoxy resin to a carboxylic acid-containing acrylic copolymer obtained by copolymerization of a carboxylic acid-containing acrylic monomer and two or more monomers and a monomer. The epoxy resin is, for example, glycidyl (meth)acrylate, 3,4-epoxybutyl (meth)acrylate, 2,3-epoxycyclohexyl (meth)acrylate, (methyl) 3,4-epoxycyclohexylmethyl acrylate or the like, the carboxylic acid-containing acrylic monomer is, for example, (meth)acrylic acid, itaconic acid, maleic acid, maleic acid monoalkyl ester, etc. More monomer is, for example, an alkyl (meth)acrylate such as methyl (meth)acrylate or hexyl (meth)acrylate, and the like is, for example, cyclohexyl (meth)acrylate, (A) Isobornyl acrylate, adamantyl (meth) acrylate, dicyclopentanyl (meth) acrylate, dicyclopentadiene (meth) acrylate Ester, benzyl (meth)acrylate, 2-methoxyethyl (meth)acrylate, 2-ethoxyethyl (meth)acrylate, styrene, α-methylstyrene, ethoxylated Styrene, N-methylmaleimide, N-ethylmaleimide, N-propyl maleimide, N-butyl maleimide, N-cyclohexylmalay Yttrium imine, (meth) acrylamide, N-methyl (meth) acrylamide, and the like.

作為側鏈具有不飽和丙烯酸鍵之丙烯酸系聚合物之另一例子可使用如下:藉由將羧酸加成在含有環氧基之丙烯酸系共聚物來獲得之共聚物;藉由在40~180℃將含有羧酸之丙烯酸系單體加成在藉由含有環氧基之丙烯酸系單體及二或更多種單體及一單體來獲得之含有環氧基之丙烯酸系共聚物來獲得之黏合劑樹脂,該含有羧酸之丙烯酸系單體為例如(甲基)丙烯酸、伊康酸、馬來酸、馬來酸單烷酯等,該含有環氧基之丙烯酸系單體為例如(甲基)丙烯酸縮水甘油酯、(甲基)丙烯酸3,4-環氧基丁酯、(甲基)丙烯酸2,3-環氧基環己酯、(甲基)丙烯酸3,4-環氧基環己基甲酯等,該二或更多種單體為例如例如(甲基)丙烯酸甲酯、(甲基)丙烯酸己酯等(甲基)丙烯酸烷酯等,該一單體為例如(甲基)丙烯酸環己酯、(甲基)丙烯酸異冰片酯、(甲基)丙烯酸金剛烷酯、(甲基)丙烯酸雙環戊烷酯、(甲基)丙烯酸雙環戊二烯酯、(甲基)丙烯酸苯甲酯、(甲基)丙烯酸2-甲氧基乙酯、(甲基)丙烯酸2-乙氧基乙酯、苯乙烯、α-甲基苯乙烯、乙醯氧基苯乙烯、N-甲基馬來醯亞胺、N-乙基馬來醯亞胺、N-丙基馬來醯亞胺、N-丁基馬來醯亞胺、N-環己基馬來醯亞胺、(甲基)丙烯醯胺、N-甲基(甲基)丙烯醯胺等。Another example of the acrylic polymer having an unsaturated acrylic bond in its side chain can be used as follows: a copolymer obtained by adding a carboxylic acid to an acrylic copolymer containing an epoxy group; by 40 to 180 °C is obtained by adding an acrylic monomer containing a carboxylic acid to an epoxy group-containing acrylic copolymer obtained by using an epoxy group-containing acrylic monomer and two or more monomers and a monomer. The binder resin, the carboxylic acid-containing acrylic monomer is, for example, (meth)acrylic acid, itaconic acid, maleic acid, maleic acid monoalkyl ester or the like, and the epoxy group-containing acrylic monomer is, for example. Glycidyl (meth)acrylate, 3,4-epoxybutyl (meth)acrylate, 2,3-epoxycyclohexyl (meth)acrylate, 3,4-cyclo(meth)acrylate Oxycyclohexyl methyl ester or the like, and the two or more monomers are, for example, alkyl (meth)acrylate such as methyl (meth)acrylate or hexyl (meth)acrylate, and the like is, for example, Cyclohexyl (meth)acrylate, isobornyl (meth)acrylate, adamantyl (meth)acrylate, dicyclopentane (meth)acrylate , (di) butyl (meth) acrylate, benzyl (meth) acrylate, 2-methoxyethyl (meth) acrylate, 2-ethoxyethyl (meth) acrylate, styrene, Α-methylstyrene, ethoxylated styrene, N-methylmaleimide, N-ethyl maleimide, N-propyl maleimide, N-butyl Malay Yttrium imine, N-cyclohexylmaleimide, (meth) acrylamide, N-methyl (meth) acrylamide, and the like.

本揭示案之實施形態之範例中,為了控制圖案特徵及提供例如耐熱性、耐化學藥劑性等薄膜性質,以感光性組成物100 wt%為基準,鹼可溶性樹脂可使用3~50 wt%、更具體而言為5~45 wt%、再更具體而言為8~40 wt%的量。In an example of the embodiment of the present disclosure, in order to control the pattern characteristics and provide film properties such as heat resistance and chemical resistance, the alkali-soluble resin may be used in an amount of 3 to 50% by weight based on 100% by weight of the photosensitive composition. More specifically, it is an amount of 5 to 45 wt%, and more specifically 8 to 40 wt%.

鹼可溶性樹脂之重量平均分子量(以聚苯乙烯來換算之藉由凝膠滲透層析法(GPC)來測得之平均分子量)可為2,000~300,000、更具體而言為4,000~100,000,密度可為1.0~10.0。The weight average molecular weight of the alkali-soluble resin (the average molecular weight measured by gel permeation chromatography (GPC) in terms of polystyrene) may be 2,000 to 300,000, more specifically 4,000 to 100,000, and the density may be It is 1.0 to 10.0.

[(b)具有乙烯性不飽和鍵之聚合性化合物]
具有乙烯性不飽和鍵之聚合性化合物有助於在圖案形成期間透過通過光反應之交聯來形成圖案,並藉由在加熱期間交聯來提供耐化學藥劑性及耐熱性。
[(b) Polymerizable compound having an ethylenically unsaturated bond]
The polymerizable compound having an ethylenically unsaturated bond contributes to pattern formation by cross-linking by photoreaction during pattern formation, and provides chemical resistance and heat resistance by crosslinking during heating.

以感光性組成物100 wt%為基準,具有乙烯性不飽和鍵之聚合性化合物可含有0.001~40 wt%、更具體而言為0.1~30 wt%、再更具體而言為1~20 wt%的量。The polymerizable compound having an ethylenically unsaturated bond may contain 0.001 to 40% by weight, more specifically 0.1 to 30% by weight, still more specifically 1 to 20%, based on 100% by weight of the photosensitive composition. The amount of %.

若添加過量的具有乙烯性不飽和鍵之聚合性化合物,則可能會過度增加交聯密度以至於減少圖案之柔軟度。If an excessive amount of a polymerizable compound having an ethylenically unsaturated bond is added, the crosslinking density may be excessively increased to reduce the softness of the pattern.

具體而言,具有乙烯性不飽和鍵之聚合性化合物可為:(甲基)丙烯酸之烷酯,例如(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸2-乙基己酯、(甲基)丙烯酸月桂酯等;(甲基)丙烯酸縮水甘油酯、具有2~14個氧化乙烯基之聚乙二醇單(甲基)丙烯酸酯、乙二醇二(甲基)丙烯酸酯、具有2~14個氧化乙烯基之聚乙二醇二(甲基)丙烯酸酯、具有2~14個氧化乙烯基之丙二醇二(甲基)丙烯酸酯、三羥甲基丙烷二(甲基)丙烯酸酯、雙酚A二縮水甘油基醚丙烯酸加成物、(甲基)丙烯酸β-羥基乙酯之鄰苯二甲酸二酯、(甲基)丙烯酸β-羥基乙酯之甲苯二異氰酸酯加成物;由多元醇與α,β-不飽和羧酸之酯化所得之化合物,例如三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、季戊四醇四(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、二季戊四醇六(甲基)丙烯酸酯或二季戊四醇三(甲基)丙烯酸酯等;多縮水甘油基化合物之丙烯酸加成物,例如三羥甲基丙烷三縮水甘油基醚丙烯酸加成物等,且該等可單獨使用或組合使用。Specifically, the polymerizable compound having an ethylenically unsaturated bond may be an alkyl (meth)acrylate such as methyl (meth)acrylate, ethyl (meth)acrylate or butyl (meth)acrylate. , 2-ethylhexyl (meth)acrylate, lauryl (meth)acrylate, etc.; glycidyl (meth)acrylate, polyethylene glycol mono(meth)acrylate having 2 to 14 oxyethylene groups Ester, ethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate having 2 to 14 ethylene oxide groups, propylene glycol di(meth)acrylic acid having 2 to 14 ethylene oxide groups Ester, trimethylolpropane di(meth)acrylate, bisphenol A diglycidyl ether acrylic acid adduct, (meth)acrylic acid β-hydroxyethyl phthalate diester, (methyl) a toluene diisocyanate adduct of β-hydroxyethyl acrylate; a compound obtained by esterification of a polyhydric alcohol with an α,β-unsaturated carboxylic acid, such as trimethylolpropane tri(meth)acrylate or pentaerythritol III ( Methyl) acrylate, pentaerythritol tetra(meth) acrylate, dipentaerythritol penta (meth) acrylate, dipentaerythritol (meth) acrylate or dipentaerythritol tri (meth) acrylate; etc.; an acrylic acid adduct of a polyglycidyl compound, such as a trimethylolpropane triglycidyl ether acrylic acid adduct, etc., and the like Used alone or in combination.

[(c)光聚合起始劑]
本揭示案之感光性組成物可使用化學式1或2之咔唑肟酯衍生化合物之一或更多種來作為光聚合起始劑。為了增加透明性並使曝光最小化,以感光性組成物100 wt%為基準,光聚合起始劑可使用0.01~10 wt%、更具體而言為0.1~5 wt%的量。
[(c) Photopolymerization initiator]
The photosensitive composition of the present disclosure may use one or more of the oxazolidinate-derived compounds of Chemical Formula 1 or 2 as a photopolymerization initiator. In order to increase the transparency and minimize the exposure, the photopolymerization initiator may be used in an amount of 0.01 to 10% by weight, more specifically 0.1 to 5% by weight based on 100% by weight of the photosensitive composition.

[(d)黏著助劑]
若有需要,則本揭示案之感光性組成物可復含有具有環氧基或胺基之矽基礎的化合物來作為黏著助劑。
[(d) Adhesive Additives]
If necessary, the photosensitive composition of the present disclosure may contain a compound having an epoxy group or an amine group as an adhesion aid.

具有環氧基或胺基之矽基礎的化合物可改善氧化銦錫(ITO)電極與感光性組成物之間之黏著力,且可強化硬化後之耐熱性特徵。具有環氧基或胺基之矽基礎的化合物可為:(3-縮水甘油氧基丙基)三甲氧基矽烷、(3-縮水甘油氧基丙基)三乙氧基矽烷、(3-縮水甘油氧基丙基)甲基二甲氧基矽烷、(3-縮水甘油氧基丙基)甲基二乙氧基矽烷、(3-縮水甘油氧基丙基)二甲基甲氧基矽烷、(3-縮水甘油氧基丙基)二甲基乙氧基矽烷、3,4-環氧基丁基三甲氧基矽烷、3,4-環氧基丁基三乙氧基矽烷、2-(3,4-環氧基環己基)乙基三甲氧基矽烷、2-(3,4-環氧基環己基)乙基三乙氧基矽烷、胺丙基三甲氧基矽烷等,且該等可單獨使用或組合使用。The compound having an epoxy group or an amine group can improve the adhesion between the indium tin oxide (ITO) electrode and the photosensitive composition, and can enhance the heat resistance characteristics after hardening. The compound having an epoxy group or an amine group can be: (3-glycidoxypropyl)trimethoxynonane, (3-glycidoxypropyl)triethoxydecane, (3-shrinkage) Glyceroxypropyl)methyldimethoxydecane, (3-glycidoxypropyl)methyldiethoxydecane, (3-glycidoxypropyl)dimethylmethoxydecane, (3-glycidoxypropyl) dimethyl ethoxy decane, 3,4-epoxy butyl trimethoxy decane, 3,4-epoxy butyl triethoxy decane, 2-( 3,4-epoxycyclohexyl)ethyltrimethoxydecane, 2-(3,4-epoxycyclohexyl)ethyltriethoxydecane, aminepropyltrimethoxydecane, etc., and the like They can be used alone or in combination.

以感光性組成物100 wt%為基準,具有環氧基或胺基之矽基礎的化合物可含有0.0001~3 wt%的量。若該量小於上述範圍,則可能會無法達到添加之效果。並且,若超過上述範圍,則會減少未暴露部分之顯影特徵以至於浮渣、殘渣等可能會殘留在下部的基板、ITO或玻璃基板上。The compound having a ruthenium group based on an epoxy group or an amine group may be contained in an amount of 0.0001 to 3% by weight based on 100% by weight of the photosensitive composition. If the amount is less than the above range, the effect of the addition may not be achieved. Further, if it exceeds the above range, the development characteristics of the unexposed portion are reduced so that scum, residue, and the like may remain on the lower substrate, ITO, or glass substrate.

[(e)其它添加物]
若有需要,則本揭示案之感光性組成物可復含有從感光劑、熱聚合起始劑、消泡劑或塗平(leveling)劑之中選出之一或更多種相容的添加物。
[(e) Other Additives]
If necessary, the photosensitive composition of the present disclosure may further comprise one or more compatible additives selected from the group consisting of a sensitizer, a thermal polymerization initiator, an antifoaming agent or a leveling agent. .

以感光性組成物100 wt%為基準,其它添加物可含有0.1~10 wt%的量。若該量小於上述範圍,則可能無法達到添加之效果。並且,若超過上述範圍,則可能會產生過量的泡沫。Other additives may be contained in an amount of 0.1 to 10% by weight based on 100% by weight of the photosensitive composition. If the amount is less than the above range, the effect of addition may not be achieved. Also, if it exceeds the above range, excessive foam may be generated.

[(f)溶劑]
本揭示案之感光性組成物添加至溶劑中且塗佈於基板上,並藉由使用遮罩來照射紫外線(UV)以鹼性顯影溶液來顯影而形成圖案。
[(f) solvent]
The photosensitive composition of the present disclosure is added to a solvent and coated on a substrate, and patterned by irradiating ultraviolet rays (UV) with a mask to develop with an alkali developing solution.

因溶劑之含量能夠以使感光性組成物之成分之總量成為100 wt%之方式控制,因此感光性組成物之其它成分之含量能夠進行各種改變。例如:以感光性組成物100 wt%為基準,溶劑可以使黏度成為1~50 cps之方式添加10~95 wt%。Since the content of the solvent can be controlled so that the total amount of the components of the photosensitive composition becomes 100% by weight, the content of the other components of the photosensitive composition can be variously changed. For example, the solvent may be added in an amount of 10 to 95% by weight so as to have a viscosity of 1 to 50 cps based on 100% by weight of the photosensitive composition.

作為溶劑,可考慮到與鹼可溶性樹脂、光聚合起始劑或其它化合物之間之相容性,來單獨使用或組合使用從下述之中選出之溶劑:乙酸乙酯、乙酸丁酯、二乙二醇二甲基醚、二乙二醇二甲基乙醚、甲氧基丙酸甲酯、乙氧基丙酸乙酯(EEP)、乳酸乙酯、丙二醇單甲基醚乙酸酯(PGMEA)、丙二醇甲基醚丙酸酯(PGMEP)、丙二醇甲基醚、丙二醇丙基醚、甲基賽璐蘇乙酸酯、乙基賽璐蘇乙酸酯、二乙二醇甲基乙酸酯、二乙二醇乙基乙酸酯、丙酮、甲基異丁基酮、環己酮、二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺(DMAc)、N-甲基-2-吡咯啶酮(NMP)、γ-丁內酯、二乙醚、乙二醇二甲基醚、二乙二醇二甲基醚(diglyme)、四氫呋喃(THF)、甲醇、乙醇、丙醇、異丙醇、甲基賽璐蘇、乙基賽璐蘇、二乙二醇甲基醚、二乙二醇乙基醚、二丙二醇甲基醚、甲苯、二甲苯、己烷、庚烷或辛烷。As the solvent, compatibility with an alkali-soluble resin, a photopolymerization initiator or other compound may be considered, and a solvent selected from the following may be used alone or in combination: ethyl acetate, butyl acetate, and Ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, methyl methoxypropionate, ethyl ethoxy propionate (EEP), ethyl lactate, propylene glycol monomethyl ether acetate (PGMEA) ), propylene glycol methyl ether propionate (PGMEP), propylene glycol methyl ether, propylene glycol propyl ether, methyl cyproterone acetate, ethyl cyproterone acetate, diethylene glycol methyl acetate , diethylene glycol ethyl acetate, acetone, methyl isobutyl ketone, cyclohexanone, dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N- Methyl-2-pyrrolidone (NMP), γ-butyrolactone, diethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether (diglyme), tetrahydrofuran (THF), methanol, ethanol, Propanol, isopropanol, methyl cyproterone, ethyl cyproterone, diethylene glycol methyl ether, diethylene glycol ethyl ether, dipropylene glycol methyl ether, toluene, xylene, hexane, g Alkane or octane.

[(g)其它光聚合起始劑]
本揭示案之感光性組成物可含有上述咔唑肟酯衍生化合物來作為單一光聚合起始劑,且可復含有從由一噻噸酮基礎的化合物、一醯基膦氧化物基礎的化合物、一苯乙酮基礎的化合物、一聯咪唑基礎的化合物、一三嗪基礎的化合物、一O-醯基肟酯基礎的化合物或一硫醇基礎的化合物所組成之群組中選出之一或更多種。
[(g) Other photopolymerization initiators]
The photosensitive composition of the present disclosure may contain the above-mentioned carbazolyl ester derivative compound as a single photopolymerization initiator, and may further contain a compound based on a compound based on a thioxanthone, a monophosphonium oxide, One or more selected from the group consisting of a monoacetophenone-based compound, a biimidazole-based compound, a triazine-based compound, an O-mercapto-decyl ester-based compound, or a monothiol-based compound A variety.

以感光性組成物100 wt%為基準,額外的光聚合起始劑可使用0.01~5 wt%。An additional photopolymerization initiator may be used in an amount of 0.01 to 5 wt% based on 100% by weight of the photosensitive composition.

噻噸酮基礎的化合物可為例如從由下述之中選出之一或更多種:噻噸酮、2-氯噻噸酮、2-甲基噻噸酮、2-異丙基噻噸酮、4-異丙基噻噸酮、2,4-二氯噻噸酮、2,4-二甲基噻噸酮、2,4-二乙基噻噸酮、2,4-二異丙基噻噸酮,但不限於此。The thioxanthone-based compound may be, for example, one or more selected from the group consisting of thioxanthone, 2-chlorothioxanthone, 2-methylthioxanthone, 2-isopropylthioxanthone , 4-isopropylthioxanthone, 2,4-dichlorothioxanthone, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2,4-diisopropyl Thioxanthone, but is not limited thereto.

醯基膦氧化物基礎的化合物可為例如從由下述之中選出之一或更多種:二苯基(2,4,6-三甲基苯甲醯基)膦氧化物或苯基雙(2,4,6-三甲基苯甲醯基)膦氧化物,但不限於此。The mercaptophosphine oxide-based compound may be, for example, one or more selected from the group consisting of diphenyl (2,4,6-trimethylbenzylidene)phosphine oxide or phenyl double (2,4,6-trimethylbenzylidene)phosphine oxide, but is not limited thereto.

苯乙酮基礎的化合物可為例如從由下述之中選出之一或更多種:2-甲基-1-[4-(甲硫基)苯基]-2-(N-嗎啉基)丙-1-酮、2-苯甲基-2-二甲胺基-1-(4-(N-嗎啉基)苯基)丁-1-酮或2-(4-甲基苯甲基)-2-(二甲胺基)-1-(4-(N-嗎啉基)苯基)丁-1-酮,但不限於此。The acetophenone-based compound may be, for example, one or more selected from the group consisting of 2-methyl-1-[4-(methylthio)phenyl]-2-(N-morpholinyl) Propan-1-one, 2-benzyl-2-ylamino-1-(4-(N-morpholinyl)phenyl)butan-1-one or 2-(4-methylbenzyl 2-(dimethylamino)-1-(4-(N-morpholinyl)phenyl)butan-1-one, but is not limited thereto.

聯咪唑基礎的化合物可為例如從由下述之中選出之一或更多種:2,2’-雙(2-氯苯基)-4,4’,5,5’-四苯基-1,2’-聯咪唑、2,2’-雙(2,4-二氯苯基)-4,4’,5,5’-四苯基-1,2’-聯咪唑或2,2’-雙(2,4,6-三氯苯基)-4,4’,5,5’-四苯基-1,2’-聯咪唑,但不限於此。The biimidazole-based compound may be, for example, one or more selected from the group consisting of 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenyl- 1,2'-biimidazole, 2,2'-bis(2,4-dichlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole or 2,2 '-Bis(2,4,6-trichlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole, but is not limited thereto.

三嗪基礎的化合物可為例如從由下述之中選出之一或更多種:2,4,6-參(三氯甲基)-s-三嗪、2-甲基-4,6-雙(三氯甲基)-s-三嗪、2-[2-(5-甲基呋喃-2-基)乙烯基]-4,6-雙(三氯甲基)-s-三嗪、2-[2-(呋喃-2-基)乙烯基]-4,6-雙(三氯甲基)-s-三嗪、2-[2-(4-二乙胺基-2-甲基苯基)乙烯基]-4,6-雙(三氯甲基)-s-三嗪、2-[2-(3,4-二甲氧基苯基)乙烯基]-4,6-雙(三氯甲基)-s-三嗪、2-(4-甲氧基苯基)-4,6-雙(三氯甲基)-s-三嗪、2-(4-乙氧基苯乙烯基)-4,6-雙(三氯甲基)-s-三嗪或2-(4-正丁氧基苯基)-4,6-雙(三氯甲基)-s-三嗪,但不限於此。The triazine-based compound may be, for example, one or more selected from the group consisting of 2,4,6-gin(trichloromethyl)-s-triazine, 2-methyl-4,6- Bis(trichloromethyl)-s-triazine, 2-[2-(5-methylfuran-2-yl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(furan-2-yl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(4-diethylamino-2-methyl) Phenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4-dimethoxyphenyl)vinyl]-4,6-double (trichloromethyl)-s-triazine, 2-(4-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-ethoxybenzene Vinyl)-4,6-bis(trichloromethyl)-s-triazine or 2-(4-n-butoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine , but not limited to this.

O-醯基肟酯基礎的化合物可為例如從由下述之中選出之一或更多種:1,2-辛二酮-1-[4-(苯硫基)苯基]-2-(O-苯甲醯基肟)、乙酮-1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]-1-(O-乙醯基肟)、乙酮-1-[9-乙基-6-(2-甲基-4-四氫呋喃基甲氧基苯甲醯基)-9H-咔唑-3-基]-1-(O-乙醯基肟)、乙酮-1-[9-乙基-6-{2-甲基-4-(2,2-二甲基-1,3-二氧戊環基)甲氧基苯甲醯基}-9H-咔唑-3-基]-1-(O-乙醯基肟)(ethanone-1-[9-ethyl-6-{2-methyl-4-(2,2-dimethyl-1,3-dioxolanyl)methoxybenzoyl}-9H-carbazol-3-yl]-1-(O-acetyloxime))或2-(乙醯氧基亞胺基)-1-(9,9’-二乙基-9H-茀-2-基)丙-1-酮,但不限於此。The O-mercaptoester based compound may be, for example, one or more selected from the group consisting of: 1,2-octanedione-1-[4-(phenylthio)phenyl]-2- (O-benzylidene hydrazine), ethyl ketone-1-[9-ethyl-6-(2-methylbenzhydryl)-9H-indazol-3-yl]-1-(O-B Ethyl ketone), ethyl ketone-1-[9-ethyl-6-(2-methyl-4-tetrahydrofurylmethoxybenzylidene)-9H-indazol-3-yl]-1-( O-acetinyl), ethyl ketone-1-[9-ethyl-6-{2-methyl-4-(2,2-dimethyl-1,3-dioxolanyl)methoxy Benzobenzyl}-9H-carbazol-3-yl]-1-(O-ethylindenyl) (ethanone-1-[9-ethyl-6-{2-methyl-4-(2,2) -dimethyl-1,3-dioxolanyl)methoxybenzoyl}-9H-carbazol-3-yl]-1-(O-acetyloxime)) or 2-(ethyloxyimino)-1-(9,9'- Diethyl-9H-indol-2-yl)propan-1-one, but is not limited thereto.

硫醇基礎的化合物可為季戊四醇肆(3-巰基丙酸酯)等,但不限於此。The thiol-based compound may be, but is not limited to, pentaerythritol lanthanum (3-mercaptopropionate).

[(h)著色材料]
本揭示案之實施形態之範例中,感光性組成物可復含有著色材料,其含有來應用於一阻劑,該阻劑是用以形成濾色器或黑色矩陣。
[(h) coloring material]
In an example of an embodiment of the present disclosure, the photosensitive composition may further comprise a coloring material which is included for application to a resist which is used to form a color filter or a black matrix.

作為著色材料,可使用各種顏料。例如包括:紅色、綠色、藍色、青藍色(cyan)、洋紅色、黃色及黑色顏料。更具體而言,可使用例如下述顏料:C.I.顏料黃12、13、14、17、20、24、55、83、86、93、109、110、117、125、137、139、147、148、153、154、166及168;C.I.顏料橙36、43、51、55、59及61;C.I.顏料紅9、97、122、123、149、168、177、180、192、215、216、217、220、223、224、226、227、228及240;C.I.顏料紫19、23、29、30、37、40及50;C.I.顏料藍15、15:1、15:4、15:6、22、60及64;C.I.顏料綠7及36;C.I.顏料棕23、25及26;C.I.顏料黑7;鈦黑等。As the coloring material, various pigments can be used. Examples include: red, green, blue, cyan, magenta, yellow, and black pigments. More specifically, for example, the following pigments: CI Pigment Yellow 12, 13, 14, 17, 20, 24, 55, 83, 86, 93, 109, 110, 117, 125, 137, 139, 147, 148 can be used. , 153, 154, 166 and 168; CI Pigment Oranges 36, 43, 51, 55, 59 and 61; CI Pigment Red 9, 97, 122, 123, 149, 168, 177, 180, 192, 215, 216, 217 , 220, 223, 224, 226, 227, 228 and 240; CI Pigment Violet 19, 23, 29, 30, 37, 40 and 50; CI Pigment Blue 15, 15:1, 15:4, 15:6, 22 60 and 64; CI Pigment Green 7 and 36; CI Pigment Brown 23, 25 and 26; CI Pigment Black 7; Titanium Black.

以感光性組成物100 wt%為基準,著色材料可含有5~50 wt%。若該量小於上述範圍,則光遮蔽性質可能無法令人滿意。並且,若超過上述範圍,則曝光或硬化可能無法令人滿意。The coloring material may contain 5 to 50% by weight based on 100% by weight of the photosensitive composition. If the amount is less than the above range, the light shielding property may be unsatisfactory. Also, if it exceeds the above range, exposure or hardening may not be satisfactory.

本揭示案之實施形態之範例中,感光性組成物可使用已知的印刷或含浸手段來供給至基板上,該手段為例如旋轉塗佈器、輥塗佈器、棒塗佈器、模具塗佈器或簾幕塗佈器,該基板是由下述所製造:鈉鈣玻璃、石英玻璃、半導體、金屬、紙、塑膠等。而且,可供給至例如膜等支撐體上,然後轉移至基板。In an example of an embodiment of the present disclosure, the photosensitive composition can be supplied to the substrate using known printing or impregnation means, such as a spin coater, a roll coater, a bar coater, a die coat. A cloth or curtain coater which is manufactured by the following: soda lime glass, quartz glass, semiconductor, metal, paper, plastic, and the like. Further, it can be supplied to a support such as a film and then transferred to the substrate.

另一態樣中,本揭示案提供一種模製品,其含述上述感光性組成物之硬化產物。In another aspect, the present disclosure provides a molded article comprising the hardened product of the above photosensitive composition.

該模製品可為一陣列平坦化膜、一絕緣膜、一濾色器、一柱狀間隔物、一外塗層、一黑色柱狀間隔物或一黑色矩陣等,但不限於此。The molded article may be an array of planarizing film, an insulating film, a color filter, a column spacer, an overcoat layer, a black column spacer or a black matrix, etc., but is not limited thereto.

另一態樣中,本揭示案提供各種顯示裝置,其含有該模製品,該顯示器包括液晶顯示器、有機發光二極體(OLED)等。In another aspect, the present disclosure provides various display devices including the molded article including a liquid crystal display, an organic light emitting diode (OLED), and the like.

以下,透過實施例及比較例來詳細敘述本揭示案之代表性的化合物,以幫助進一步理解本揭示案。然而,本揭示案之實施形態之範例能夠改變為各種其它形式且其不應被理解為本揭示案之範圍受下述實施例所限制。本揭示案之實施例是提供來對本揭示案所屬技術領域中具有通常知識者更完整地解釋本揭示案。Hereinafter, representative compounds of the present disclosure will be described in detail by way of examples and comparative examples to help further understanding the present disclosure. However, the examples of the embodiments of the present disclosure can be changed to various other forms and should not be construed as limiting the scope of the disclosure by the following examples. The embodiments of the present disclosure are provided to more fully explain the present disclosure to those of ordinary skill in the art.

<咔唑肟酯衍生化合物之製備>
[製造例1:1-(9-(4-甲氧基苯基)-9H-咔唑-3-基]-1-丙酮肟)(O-乙酸酯)[化學式3-1]]
<Preparation of oxazolidine derivative compounds>
[Production Example 1: 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl]-1-propanone oxime) (O-acetate) [Chemical Formula 3-1]]

[步驟1:9-(4-甲氧基苯基)-9H-咔唑之合成]
在添加三乙二醇二甲基醚(triglyme)(40 mL)至反應器中然後在其中添加咔唑(30 g,170.5 mmol)、4-碘苯甲醚(49.8 g,204.3 mmol)、銅粉末(11.34 g,180 mmol)及碳酸鉀(58.8 g,423.2 mmol)後,在200℃將混合物攪拌20小時。在反應完成後,將混合物冷卻至室溫,並藉由添加乙酸乙酯(300 mL)後攪拌30分鐘來結晶化。藉由將溶液過濾而獲得固體後,將該固體分別在丙酮(300 mL)及二氯甲烷(300 mL)中攪拌,然後以水來清洗。
[Step 1: Synthesis of 9-(4-methoxyphenyl)-9H-carbazole]
Add triethylene glycol dimethyl ether (40 mL) to the reactor and then add carbazole (30 g, 170.5 mmol), 4-iodoanisole (49.8 g, 204.3 mmol), copper After the powder (11.34 g, 180 mmol) and potassium carbonate (58.8 g, 423.2 mmol), the mixture was stirred at 200 ° C for 20 hours. After the reaction was completed, the mixture was cooled to room temperature and crystallized by adding ethyl acetate (300 mL) and stirring for 30 minutes. After solids were obtained by filtering the solution, the solid was stirred in acetone (300 mL) and dichloromethane (300 mL), and then washed with water.

所獲得之固體為雜質而丟棄,並在減壓下在40℃將濾液蒸餾。藉由儲存在冰箱中1天來使所得之產物沉澱。然後,在添加石油醚(約200 mL)然後過濾後,以丙酮來使所產生之固體再結晶,而獲得目標化合物9-(4-甲氧基苯基)-9H-咔唑(40.7 g,87.4%)。
The solid obtained was discarded as an impurity, and the filtrate was distilled at 40 ° C under reduced pressure. The resulting product was precipitated by storage in a refrigerator for 1 day. Then, after adding petroleum ether (about 200 mL) and then filtering, the resulting solid was recrystallized from acetone to obtain the target compound 9-(4-methoxyphenyl)-9H-carbazole (40.7 g, 87.4%).

[步驟2:1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮之合成]
在添加氯化鋁(5.91 g,43.9 mmol)至二氯甲烷(200 mL)中、冷卻至-10℃或更低及攪拌10分鐘後,添加步驟1中所得之9-(4-甲氧基苯基)-9H-咔唑(10.0 g,36.3 mmol),並將混合物攪拌30分鐘。在逐滴添加溶於二氯甲烷(25 mL)中之丙醯氯(3.89 mL,43.9 mmol)50分鐘後,將混合物攪拌30分鐘。在添加反應溶液至由冰(490 g)及水(500 mL)所組成之冰水中並攪拌30分鐘後,將水層去除,並以碳酸氫鈉水溶液來將有機層充分清洗。然後,將有機層以無水硫酸鎂來乾燥、過濾然後在減壓下蒸餾,而獲得目標化合物1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(11.8 g,98.9%)。
[Step 2: Synthesis of 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one]
After adding aluminum chloride (5.91 g, 43.9 mmol) to dichloromethane (200 mL), cooling to -10 ° C or lower and stirring for 10 minutes, the 9-(4-methoxy group) obtained in the step 1 was added. Phenyl)-9H-carbazole (10.0 g, 36.3 mmol), and the mixture was stirred for 30 min. After adding propionyl chloride (3.89 mL, 43.9 mmol) in dichloromethane (25 mL) dropwise dropwise for 50 min, the mixture was stirred for 30 min. After the reaction solution was added to ice water consisting of ice (490 g) and water (500 mL) and stirred for 30 minutes, the aqueous layer was removed, and the organic layer was thoroughly washed with an aqueous sodium hydrogen carbonate solution. Then, the organic layer was dried over anhydrous magnesium sulfate, filtered, and then distilled under reduced pressure to give the title compound 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl)propyl- 1-ketone (11.8 g, 98.9%).

[步驟3:1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)-1-丙酮-2-肟之合成]
在添加步驟2中所得之1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(6.0 g,18.2 mmol)、四氫呋喃(132 mL)及35%氫氯酸(8.7 mL)至反應器中後,將混合物攪拌30分鐘。在逐滴添加溶於四氫呋喃(10 mL)中之亞硝酸異戊酯(5.1 mL,36.4 mmol)之溶液30分鐘後,將混合物攪拌50分鐘。然後,以乙酸乙酯來將產物萃取,並以碳酸氫鈉水溶液來充分清洗。將萃取後之有機層使用無水硫酸鎂來乾燥、過濾然後在減壓下蒸餾,而獲得粗糙產物。使用二氯甲烷來將所獲得之粗糙產物清洗3次,而獲得目標化合物1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)-1-丙酮-2-肟(2.03 g,31.1%)。
[Step 3: Synthesis of 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl)-1-propanone-2-indole]
1-(9-(4-Methoxyphenyl)-9H-indazol-3-yl)propan-1-one (6.0 g, 18.2 mmol) obtained in Step 2, tetrahydrofuran (132 mL) After 35% hydrochloric acid (8.7 mL) was added to the reactor, the mixture was stirred for 30 minutes. After 30 minutes of dropwise addition of a solution of isoamyl nitrite (5.1 mL, 36.4 mmol) in tetrahydrofuran (10 mL), the mixture was stirred for 50 min. The product was then extracted with ethyl acetate and washed thoroughly with aqueous sodium bicarbonate. The organic layer after extraction was dried using anhydrous magnesium sulfate, filtered, and then distilled under reduced pressure to give a crude product. The obtained crude product was washed 3 times with dichloromethane to obtain the title compound 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl)-1-propanone-2-肟 (2.03 g, 31.1%).

[步驟4:1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)-1-丙酮肟(O-乙酸酯)之合成]
在添加步驟3中所得之1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)-1-丙酮-2-肟(0.5 g,1.4 mmol)至乙酸乙酯中並冷卻至-10℃或更低後,逐滴添加三乙胺(0.39 mL,2.8 mmol),並將混合物攪拌10分鐘。然後,在添加溶於乙酸乙酯(1 mL)中之乙醯氯(0.22 mL,3.08 mmol)之溶液10分鐘後,將混合物攪拌30分鐘。以二氯甲烷來將反應溶液萃取,並以碳酸氫鈉水溶液來充分清洗。將萃取後之有機層使用無水硫酸鎂來乾燥、過濾然後在減壓下蒸餾,而獲得目標化合物1-(9-(4-甲氧基苯基)-9H-咔唑-3-基)-1-丙酮肟(O-乙酸酯)(0.53 g,94.3%)。

分解點:241.8℃
[Step 4: Synthesis of 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl)-1-propanone oxime (O-acetate)]
1-(9-(4-Methoxyphenyl)-9H-indazol-3-yl)-1-propanone-2-indole (0.5 g, 1.4 mmol) obtained in Step 3 was added to ethyl acetate After cooling to -10 ° C or lower, triethylamine (0.39 mL, 2.8 mmol) was added dropwise, and the mixture was stirred for 10 min. Then, after adding a solution of ethyl hydrazine chloride (0.22 mL, 3.08 mmol) in ethyl acetate (1 mL) for 10 minutes, the mixture was stirred for 30 minutes. The reaction solution was extracted with dichloromethane and thoroughly washed with an aqueous sodium hydrogencarbonate solution. The organic layer after extraction was dried using anhydrous magnesium sulfate, filtered, and then distilled under reduced pressure to give the title compound 1-(9-(4-methoxyphenyl)-9H-indazol-3-yl)- 1-Acetone oxime (O-acetate) (0.53 g, 94.3%).

Decomposition point: 241.8 ° C

[實施例2~12]
在與實施例1中相同的條件下合成表1中敘述之咔唑肟酯衍生化合物。
[Examples 2 to 12]
The oxazolidinate derivative compound described in Table 1 was synthesized under the same conditions as in Example 1.

[表1]
[Table 1]

[實施例13:2-(羥基亞胺基)-1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(O-乙酸酯)之製備[化學式3-13]]
[Example 13: 2-(hydroxyimino)-1-(6-methoxy-9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one ( Preparation of O-acetate) [Chemical Formula 3-13]]

[步驟1:3-甲氧基-9H-咔唑之合成]
在於氮氣環境中添加3-溴-9H-咔唑(19.8 g,78.8 mmol)、碘化銅(8.0 g,41.76 mmol)、25%甲醇鈉甲醇溶液(750 mL)、乙酸乙酯(15 mL)及甲苯(15 mL)至反應器中後,在90℃將混合物回流4天。在反應完成後,將反應混合物冷卻至室溫。然後,將反應溶液轉移至燒杯中,並在添加水(300 mL)及二氯甲烷(300 mL)至燒杯中後,將混合物攪拌1小時。透過2~3 cm大小的矽膠(40~400篩)過濾器來將混合物溶液過濾,而將未溶解之雜質去除。以二氯甲烷(300 mL)來將濾液萃取3次,並將有機層使用無水硫酸鎂來乾燥、過濾、在減壓下蒸餾然後再結晶(二氯甲烷:己烷=1:1),而獲得目標化合物3-甲氧基-9H-咔唑(10.3 g,66.4%)。
[Step 1: Synthesis of 3-methoxy-9H-carbazole]
Add 3-bromo-9H-carbazole (19.8 g, 78.8 mmol), copper iodide (8.0 g, 41.76 mmol), 25% sodium methoxide in methanol (750 mL), ethyl acetate (15 mL). After toluene (15 mL) was added to the reactor, the mixture was refluxed at 90 ° C for 4 days. After the reaction was completed, the reaction mixture was cooled to room temperature. Then, the reaction solution was transferred to a beaker, and after adding water (300 mL) and dichloromethane (300 mL) to a beaker, the mixture was stirred for 1 hour. The mixture solution was filtered through a 2 to 3 cm size silicone (40 to 400 sieve) filter to remove undissolved impurities. The filtrate was extracted three times with dichloromethane (300 mL), and the organic layer was dried over anhydrous magnesium sulfate, filtered, distilled under reduced pressure and then recrystallized (dichloromethane:hexane = 1:1) The title compound 3-methoxy-9H-carbazole (10.3 g, 66.4%) was obtained.

[步驟2:3-甲氧基-9-(4-甲氧基苯基)-9H-咔唑之合成]
在添加步驟1中所得之3-甲氧基-9H-咔唑(3.0 g,15.2 mmol)、4-碘苯甲醚(4.34 g,17.8 mmol)、銅粉末(1.01 g,15.8 mmol)、碳酸鉀(5.28 g,38 mmol)及三乙二醇二甲基醚(5.3 mL,29.3 mmol)至反應器中,並在200℃將混合物攪拌24小時。在反應完成後,將混合物冷卻至室溫,然後在添加二氯甲烷後攪拌1小時(60 mL)。透過2~3 cm大小的矽膠(40~400篩)過濾器來將反應溶液過濾。然後,在藉由在減壓下蒸餾來將殘留在濾液中之二氯甲烷及三乙二醇二甲基醚去除後,藉由管柱(二氯甲烷:己烷=1:5)分離,而獲得目標化合物3-甲氧基-9-(4-甲氧基苯基)-9H-咔唑(4.05 g,88.2%)。
[Step 2: Synthesis of 3-methoxy-9-(4-methoxyphenyl)-9H-carbazole]
3-methoxy-9H-carbazole (3.0 g, 15.2 mmol), 4-iodoanisole (4.34 g, 17.8 mmol), copper powder (1.01 g, 15.8 mmol), carbonic acid obtained in the addition of Step 1. Potassium (5.28 g, 38 mmol) and triethylene glycol dimethyl ether (5.3 mL, 29.3 mmol) were placed in the reactor and the mixture was stirred at 200 ° C for 24 hours. After the reaction was completed, the mixture was cooled to room temperature and then stirred for 1 hour (60 mL) after the addition of dichloromethane. The reaction solution was filtered through a 2 to 3 cm size silicone (40 to 400 sieve) filter. Then, the dichloromethane and triethylene glycol dimethyl ether remaining in the filtrate were removed by distillation under reduced pressure, and then separated by a column (dichloromethane:hexane = 1:5). The title compound 3-methoxy-9-(4-methoxyphenyl)-9H-carbazole (4.05 g, 88.2%) was obtained.

[步驟3:1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮之合成]
在添加氯化鋁(2.32 g,17.2 mmol)至二氯甲烷(40 mL)中後,將混合物冷卻至-10℃或更低。在逐滴添加步驟2中所得之3-甲氧基-9-(4-甲氧基苯基)-9H-咔唑(4.0 g,13.2 mmol)至二氯甲烷(5 mL)中後,將混合物攪拌20分鐘。在逐滴添加丙醯氯(1.52 mL,17.2 mmol)30分鐘後,將混合物攪拌20分鐘。在反應完成後,將反應溶液注入水(200 mL)中、攪拌1小時,然後藉由添加二氯甲烷(100 mL)來將有機層萃取。以碳酸氫鈉水溶液來將萃取後之有機層充分清洗。將萃取後之有機層使用無水硫酸鎂來乾燥、過濾然後在減壓下蒸餾,而獲得目標化合物1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(4.5 g,94.7%)。
[Step 3: Synthesis of 1-(6-methoxy-9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one]
After adding aluminum chloride (2.32 g, 17.2 mmol) to dichloromethane (40 mL), the mixture was cooled to -10 ° C or lower. After the 3-methoxy-9-(4-methoxyphenyl)-9H-carbazole (4.0 g, 13.2 mmol) obtained in Step 2 was added dropwise to dichloromethane (5 mL), The mixture was stirred for 20 minutes. After adding propional chloride (1.52 mL, 17.2 mmol) dropwise for 30 minutes, the mixture was stirred for 20 minutes. After completion of the reaction, the reaction solution was poured into water (200 mL), stirred for 1 hour, and then the organic layer was extracted by adding dichloromethane (100 mL). The extracted organic layer was thoroughly washed with an aqueous solution of sodium hydrogencarbonate. The organic layer after extraction was dried using anhydrous magnesium sulfate, filtered, and then distilled under reduced pressure to give the title compound 1-(6-methoxy-9-(4-methoxyphenyl)-9H-carbazole. 3-yl)propan-1-one (4.5 g, 94.7%).

[步驟4:2-(羥基亞胺基)-1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮之合成]
添加步驟3中所得之1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(4.91 g,13.7 mmol)及35%氫氯酸(2.4 mL,27.4 mmol)至四氫呋喃(40 mL)中並攪拌30分鐘。然後,在逐滴添加溶於四氫呋喃(8 mL)中之亞硝酸異戊酯(3.83 mL,27.4 mmol)之溶液20分鐘後,將混合物攪拌5小時。在反應完成後,藉由添加乙酸乙酯(100 mL)來將有機層萃取。以碳酸氫鈉水溶液來將萃取後之有機層充分清洗。將萃取後之有機層使用無水硫酸鎂來乾燥然後過濾。然後,在減壓下蒸餾後,藉由管柱(乙酸乙酯:己烷=1:4)分離,而獲得目標化合物2-(羥基亞胺基)-1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(1.63 g,30.7%) 。
[Step 4: Synthesis of 2-(hydroxyimino)-1-(6-methoxy-9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one ]
Add 1-(6-methoxy-9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one (4.91 g, 13.7 mmol) obtained in Step 3 and 35 Hydrochloric acid (2.4 mL, 27.4 mmol) was added to tetrahydrofuran (40 mL) and stirred for 30 min. Then, after a solution of isoamyl nitrite (3.83 mL, 27.4 mmol) dissolved in tetrahydrofuran (8 mL) was added dropwise for 20 minutes, the mixture was stirred for 5 hours. After the reaction was completed, the organic layer was extracted by adding ethyl acetate (100 mL). The extracted organic layer was thoroughly washed with an aqueous solution of sodium hydrogencarbonate. The extracted organic layer was dried using anhydrous magnesium sulfate and then filtered. Then, after distilling under reduced pressure, the title compound (2-(hydroxyimino)-1-(6-methoxy-9) was obtained by the column (ethyl acetate:hexane = 1:1). -(4-Methoxyphenyl)-9H-indazol-3-yl)propan-1-one (1.63 g, 30.7%).

[步驟5:2-(羥基亞胺基)-1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(O-乙酸酯)之合成]
添加步驟4中所得之2-(羥基亞胺基)-1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(0.76 g,1.96 mmol)至乙酸乙酯(15 mL)中並冷卻至-10℃或更低。在添加三乙胺(0.55 mL,3.92 mmol)後,將混合物攪拌10分鐘。然後,在逐滴添加溶於乙酸乙酯(2 mL)中之乙醯氯(0.29 mL,3.92 mmol)之溶液5分鐘後,將混合物攪拌20分鐘。在反應完成後,藉由添加二氯甲烷(50 mL)來將有機層萃取,並以碳酸氫鈉水溶液來將萃取後之有機層充分清洗。將萃取後之有機層使用無水硫酸鎂來乾燥並在減壓下蒸餾,而獲得目標化合物2-(羥基亞胺基)-1-(6-甲氧基-9-(4-甲氧基苯基)-9H-咔唑-3-基)丙-1-酮(O-乙酸酯)(0.77 g,91.3%)。

分解點:248.3℃
[Step 5: 2-(hydroxyimino)-1-(6-methoxy-9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one (O -acetate synthesis]
Addition of 2-(hydroxyimino)-1-(6-methoxy-9-(4-methoxyphenyl)-9H-indazol-3-yl)propan-1-one obtained in Step 4. (0.76 g, 1.96 mmol) to ethyl acetate (15 mL) and cooled to -10 ° C or lower. After the addition of triethylamine (0.55 mL, 3.92 mmol), the mixture was stirred for 10 min. Then, after a solution of ethyl hydrazine chloride (0.29 mL, 3.92 mmol) dissolved in ethyl acetate (2 mL) was added dropwise for 5 minutes, the mixture was stirred for 20 minutes. After completion of the reaction, the organic layer was extracted by adding dichloromethane (50 mL), and the extracted organic layer was thoroughly washed with aqueous sodium hydrogen carbonate. The organic layer after extraction was dried using anhydrous magnesium sulfate and distilled under reduced pressure to give the title compound 2-(hydroxyimino)-1-(6-methoxy-9-(4-methoxybenzene). Base 9-9-oxazol-3-yl)propan-1-one (O-acetate) (0.77 g, 91.3%).

Decomposition point: 248.3 ° C

[實施例14~18]
在與實施例13中相同的條件下合成表2中敘述之咔唑肟酯衍生化合物。
[Examples 14 to 18]
The oxazolidinate derivative compound described in Table 2 was synthesized under the same conditions as in Example 13.

[表2]
[Table 2]

<鹼可溶性樹脂之製備>
[製備例1:丙烯酸系聚合物(a-1)之製備]
在添加丙二醇甲基醚乙酸酯(PGMEA)200 mL及偶氮雙異丁腈(AIBN)1.5 g至500 mL聚合反應器中後,以丙烯酸系單體之固體成分為基準,添加莫耳比20:20:40:20的甲基丙烯酸、縮水甘油基甲基丙烯酸、甲基甲基丙烯酸及雙環戊基丙烯酸40 wt%。藉由在氮氣環境中在70℃將混合物攪拌5小時來進行聚合,而製備丙烯酸系聚合物(a-1)。製備之聚合物(a-1)之重量平均分子量25,000及密度1.9。
<Preparation of alkali soluble resin>
[Preparation Example 1: Preparation of Acrylic Polymer (a-1)]
After adding propylene glycol methyl ether acetate (PGMEA) 200 mL and azobisisobutyronitrile (AIBN) 1.5 g to 500 mL polymerization reactor, molar ratio was added based on the solid content of the acrylic monomer. 20:20:40:20 methacrylic acid, glycidyl methacrylic acid, methyl methacrylic acid, and dicyclopentylactyl acid 40 wt%. The acrylic polymer (a-1) was prepared by carrying out polymerization by stirring the mixture at 70 ° C for 5 hours in a nitrogen atmosphere. The prepared polymer (a-1) had a weight average molecular weight of 25,000 and a density of 1.9.

[製備例2:丙烯酸系聚合物(a-2)之製備]
在添加丙二醇甲基醚乙酸酯200 mL及AIBN 1.0 g至500 mL聚合反應器中後,以丙烯酸系單體之固體成分為基準,添加莫耳比40:20:20:20的甲基丙烯酸、苯乙烯、甲基甲基丙烯酸及環己基甲基丙烯酸40 wt%。然後,藉由在氮氣環境中在70℃將混合物攪拌5小時來進行聚合,而合成共聚物。然後,在以所有單體100 mol為基準來添加N,N-二甲基苯胺0.3 g及縮水甘油基甲基丙烯酸20 mol至反應器中後,藉由在100℃攪拌10小時,而製備側鏈具有不飽和丙烯酸鍵之丙烯酸系聚合物(a-2)。製備之丙烯酸系聚合物(a-2)之重量平均分子量20,000及密度2.0。
[Preparation Example 2: Preparation of Acrylic Polymer (a-2)]
After adding propylene glycol methyl ether acetate 200 mL and AIBN 1.0 g to 500 mL polymerization reactor, methacrylic acid with a molar ratio of 40:20:20:20 was added based on the solid content of the acrylic monomer. , styrene, methyl methacrylic acid and cyclohexyl methacrylic acid 40 wt%. Then, the copolymer was synthesized by carrying out polymerization by stirring the mixture at 70 ° C for 5 hours in a nitrogen atmosphere. Then, after adding N,N-dimethylaniline 0.3 g and glycidyl methacrylic acid 20 mol to the reactor on the basis of 100 mol of all monomers, the mixture was prepared by stirring at 100 ° C for 10 hours. The chain has an acrylic polymer (a-2) having an unsaturated acrylic bond. The prepared acrylic polymer (a-2) had a weight average molecular weight of 20,000 and a density of 2.0.

[製備例3:丙烯酸系聚合物(a-3)之製備]
在添加丙二醇甲基醚乙酸酯200 mL及AIBN 1.0 g至500 mL聚合反應器中後,以丙烯酸系單體之固體成分為基準,添加莫耳比40:20:20:20的縮水甘油基甲基丙烯酸、苯乙烯、甲基甲基丙烯酸及環己基甲基丙烯酸40 wt%。然後,藉由在氮氣環境中在70℃將混合物攪拌5小時來進行聚合,而合成共聚物。然後,在以所有單體100 mol為基準來添加N,N-二甲基苯胺0.3 g及丙烯酸20 mol至反應器中後,藉由在100℃攪拌10小時,而製備側鏈具有不飽和丙烯酸鍵之丙烯酸系聚合物(a-3)。製備之丙烯酸系聚合物(a-3)之重量平均分子量18,000及密度1.8。
[Preparation Example 3: Preparation of Acrylic Polymer (a-3)]
After adding propylene glycol methyl ether acetate 200 mL and AIBN 1.0 g to 500 mL polymerization reactor, a glycidyl group with a molar ratio of 40:20:20:20 was added based on the solid content of the acrylic monomer. Methacrylic acid, styrene, methyl methacrylic acid and cyclohexyl methacrylic acid 40 wt%. Then, the copolymer was synthesized by carrying out polymerization by stirring the mixture at 70 ° C for 5 hours in a nitrogen atmosphere. Then, after adding N,N-dimethylaniline 0.3 g and 20 mol of acrylic acid to the reactor on the basis of 100 mol of all monomers, the side chain was made to have unsaturated acrylic acid by stirring at 100 ° C for 10 hours. Key acrylic polymer (a-3). The prepared acrylic polymer (a-3) had a weight average molecular weight of 18,000 and a density of 1.8.

<感光性組成物之製備>
[實施例19~34:感光性組成物之製備]
在依據表3中敘述之組成物來連續添加鹼可溶性樹脂、具有乙烯性不飽和鍵之聚合性化合物、本揭示案之光聚合起始劑及FC-430(3M公司之塗平劑)至裝備有抗UV膜及攪拌器之反應器中並在室溫(23℃)攪拌後,藉由添加PGMEA來作為溶劑以使組成物之所有成分為100 wt%,而製備實施例19~34之感光性組成物。
<Preparation of photosensitive composition>
[Examples 19 to 34: Preparation of photosensitive composition]
An alkali-soluble resin, a polymerizable compound having an ethylenically unsaturated bond, a photopolymerization initiator of the present disclosure, and FC-430 (a coating agent of 3M) are continuously added to the composition according to the composition described in Table 3. In a reactor having an anti-UV film and a stirrer and stirring at room temperature (23 ° C), the photosensitivity of Examples 19 to 34 was prepared by adding PGMEA as a solvent so that all components of the composition were 100 wt%. Sexual composition.

<著色感光性組成物之製備>
[實施例35~36:著色感光性組成物之製備]
<Preparation of coloring photosensitive composition>
[Examples 35 to 36: Preparation of coloring photosensitive composition]

除了如表3中敘述般復添加以固體成分25 wt%來分散在PGMEA中之碳黑之分散體50 wt%以外,其餘以與實施例19中相同的方式製備實施例35之著色感光性組成物。而且,除了復添加以固體成分25 wt%來分散在PGMEA中之顏料紅177(P.R. 177)之分散體50 wt%以外,其餘以與實施例19中相同的方式製備實施例36之著色感光性組成物。The coloring photosensitive composition of Example 35 was prepared in the same manner as in Example 19 except that 50 wt% of the carbon black dispersion dispersed in PGMEA as a solid component of 25 wt% was added as described in Table 3. Things. Further, the coloring sensitivity of Example 36 was prepared in the same manner as in Example 19, except that 50 wt% of the dispersion of Pigment Red 177 (PR 177) dispersed in PGMEA as a solid component of 25 wt% was added. Composition.

[實施例37]
除了如表3中敘述般將化學式4之化合物與實施例1之化合物一起使用來作為光聚合起始劑以外,其餘以與實施例19中相同的方式製備感光性組成物。
<化學式4>
[Example 37]
A photosensitive composition was prepared in the same manner as in Example 19 except that the compound of Chemical Formula 4 was used together with the compound of Example 1 as a photopolymerization initiator as described in Table 3.
<Chemical Formula 4>

<成分>
(a)鹼可溶性樹脂:製備例1~3之丙烯酸系聚合物(a-1~a-3)
(b)具有乙烯性不飽和鍵之聚合性化合物
-b-1:二季戊四醇六丙烯酸酯
-b-2:二季戊四醇五丙烯酸酯
-b-3:季戊四醇三丙烯酸酯
-b-4:季戊四醇三甲基丙烯酸酯
-b-5:三羥甲基丙烷三丙烯酸酯
-b-6:乙二醇二丙烯酸酯
-b-7:雙酚-A二縮水甘油基醚丙烯酸加成物
-b-8:三羥甲基丙烷三縮水甘油基醚丙烯酸加成物
(c)光聚合起始劑:實施例1~18中製備之咔唑肟酯衍生化合物
(e)塗平劑:FC-430(3M公司之塗平劑)
(h)著色材料
h-1:碳黑(固體成分25 wt%)
h-2:顏料紅177(P.R. 177)(固體成分25 wt%)
<component>
(a) Alkali-soluble resin: Acrylic polymers (a-1 to a-3) of Preparation Examples 1 to 3
(b) Polymerizable compound having an ethylenically unsaturated bond-b-1: dipentaerythritol hexaacrylate-b-2: dipentaerythritol pentaacrylate-b-3: pentaerythritol triacrylate-b-4: pentaerythritol trimethyl Acrylate-b-5: trimethylolpropane triacrylate-b-6: ethylene glycol diacrylate-b-7: bisphenol-A diglycidyl ether acrylic acid adduct-b-8: Trimethylolpropane triglycidyl ether acrylic acid adduct
(c) Photopolymerization initiator: the carbazole oxime derivative compound prepared in Examples 1 to 18
(e) Coating agent: FC-430 (3M company's coating agent)
(h) coloring material
H-1: carbon black (solid content 25 wt%)
H-2: Pigment Red 177 (PR 177) (solid content 25 wt%)

[表3]
[table 3]

[比較例1]
除了使用化學式5之化合物取代實施例1之化學式3-1之化合物來作為光聚合起始劑以外,其餘以與實施例19中相同的方式製備感光性組成物。
<化學式5>
[Comparative Example 1]
A photosensitive composition was prepared in the same manner as in Example 19 except that the compound of Chemical Formula 5 was used instead of the compound of Chemical Formula 3-1 of Example 1 as a photopolymerization initiator.
<Chemical Formula 5>

[比較例2]
除了使用化學式6之化合物取代實施例1之化學式3-1之化合物來作為光聚合起始劑以外,其餘以與實施例19中相同的方式製備感光性組成物。
<化學式6>
[Comparative Example 2]
A photosensitive composition was prepared in the same manner as in Example 19 except that the compound of Chemical Formula 6 was used instead of the compound of Chemical Formula 3-1 of Example 1 as a photopolymerization initiator.
<Chemical Formula 6>

<感光性組成物之評估>
在玻璃基板上對實施例19~37及比較例1~2中製備之感光性組成物進行評估。例如感度、膜殘留率、圖案安定性、耐化學藥劑性、柔軟度等感光性組成物之性能之測量結果是如表4所示。
<Evaluation of photosensitive composition>
The photosensitive compositions prepared in Examples 19 to 37 and Comparative Examples 1 and 2 were evaluated on a glass substrate. The measurement results of the properties of the photosensitive composition such as sensitivity, film residual ratio, pattern stability, chemical resistance, and softness are shown in Table 4.

1)感度
在將光阻旋轉塗佈於玻璃基板上且在熱板上在100℃乾燥1分鐘並使用階段遮罩(step mask)來進行曝光後,在0.04% KOH水溶液中進行顯影。將維持階段遮罩圖案之初始厚度之80%之曝光之量評估為感度。
1) Sensitivity After the photoresist was spin-coated on a glass substrate and dried on a hot plate at 100 ° C for 1 minute and exposed using a step mask, development was carried out in a 0.04% KOH aqueous solution. The amount of exposure that maintains 80% of the initial thickness of the stage mask pattern is evaluated as sensitivity.

2)膜殘留率
在使用旋轉塗佈器來將感光性組成物供給至基板上後,在100℃進行預烤1分鐘並以365 nm來進行曝光,在230℃進行後烤20分鐘,並測量後烤前後之光阻膜之厚度之比例(%)。
2) Film Residual Rate After the photosensitive composition was supplied onto the substrate using a spin coater, prebaking was performed at 100 ° C for 1 minute, exposure was performed at 365 nm, post-baking was performed at 230 ° C for 20 minutes, and measurement was performed. The ratio (%) of the thickness of the photoresist film before and after baking.

3)圖案安定性
沿著與孔洞圖案垂直之方向將其上形成有光阻圖案之矽晶圓切割,並在圖案之剖面方向觀察。若圖案之側壁與基板之間之角度為55,則將圖案安定性評估為’良好’,且若膜縮小,則將圖案安定性評估為’縮小’。
3) Pattern stability The silicon wafer on which the photoresist pattern is formed is cut in a direction perpendicular to the hole pattern, and is observed in the cross-sectional direction of the pattern. If the angle between the side wall of the pattern and the substrate is 55, the pattern stability is evaluated as 'good', and if the film is reduced, the pattern stability is evaluated as 'reduction'.

4)耐化學藥劑性
藉由使用旋轉塗佈器來將感光性組成物供給至基板上並進行預烤及後烤而形成光阻膜後,將該光阻膜在40℃在清除劑(stripper)溶液中浸漬10分鐘,然後調查光阻膜之穿透率及厚度之差異。若穿透率及厚度改變2%或更小,則將耐化學藥劑性評估為’良好’,且若穿透率及厚度改變超過2%,則評估為’不良’。
4) Chemical resistance The photoresist film was formed at 40 ° C in a scavenger by using a spin coater to supply a photosensitive composition onto a substrate and pre-baking and post-baking to form a photoresist film. The solution was immersed for 10 minutes, and then the difference in transmittance and thickness of the photoresist film was investigated. If the penetration rate and thickness were changed by 2% or less, the chemical resistance was evaluated as 'good', and if the transmittance and thickness were changed by more than 2%, it was evaluated as 'bad'.

5)柔軟度
在將感光性組成物旋轉塗佈於基板上後,在100℃進行預烤1分鐘並進行曝光,藉由以KOH水溶液來進行顯影,而形成20 μm×20 μm圖案。對形成之圖案藉由在230℃進行後烤20分鐘來交聯,並使用奈米壓痕機(nanoindenter)來測量圖案之柔軟度。若在5 g.f的負載下總變量為500 nm或更大,則將柔軟度評估為’良好’,且若變量小於500 nm,則評估為’不良’。
5) Softness After the photosensitive composition was spin-coated on a substrate, it was prebaked at 100 ° C for 1 minute, exposed, and developed with a KOH aqueous solution to form a 20 μm × 20 μm pattern. The formed pattern was crosslinked by post-baking at 230 ° C for 20 minutes, and the softness of the pattern was measured using a nanoindenter. If the total variable is 500 nm or more under a load of 5 gf, the softness is evaluated as 'good', and if the variable is less than 500 nm, it is evaluated as 'bad'.

[表4]
[Table 4]

由表4可知,本揭示案之咔唑肟酯衍生化合物當作為感光性組成物之光聚合起始劑使用時,即使使用小量,仍顯示顯著優異的感度以及優異的物理性質,例如膜殘留率、圖案安定性、耐化學藥劑性、柔軟度等。於是已證實,能夠藉由使在TFT-LCD製造過程中之曝光及後烤處理期間從光聚合起始劑發生之釋氣最小化來降低污染,且能夠使由其所產生之缺陷最小化。As is apparent from Table 4, when the carbazole oxime ester-derived compound of the present disclosure is used as a photopolymerization initiator of a photosensitive composition, it exhibits remarkably excellent sensitivity and excellent physical properties such as film residue even when used in a small amount. Rate, pattern stability, chemical resistance, softness, etc. Thus, it has been confirmed that the contamination can be reduced by minimizing the outgas generated from the photopolymerization initiator during the exposure and post-baking treatment in the TFT-LCD manufacturing process, and the defects generated therefrom can be minimized.

國內寄存資訊 (請依寄存機構、日期、號碼順序註記)
Domestic deposit information (please note in the order of the depository, date, number)
no

國外寄存資訊 (請依寄存國家、機構、日期、號碼順序註記)
Foreign deposit information (please note in the order of country, organization, date, number)
no

Claims (12)

一種咔唑肟酯衍生化合物,其是如化學式1或化學式2所示: <化學式1>     <化學式2> 化學式1及2中, A為氧或硫; R1 及R4 分別獨立地為(C1 ~C20 )烷基; R2 為(C1 ~C20 )烷基、(C6 ~C20 )芳基、(C1 ~C20 )烷氧基、(C6 ~C20 )芳基(C1 ~C20 )烷基、羥基(C1 ~C20 )烷基、羥基(C1 ~C20 )烷氧基(C1 ~C20 )烷基或(C3 ~C20 )環烷基;且 R3 為(C1 ~C20 )烷基、(C6 ~C20 )芳基、(C6 ~C20 )芳基(C1 ~C20 )烷基、(C3 ~C20 )環烷基或(C3 ~C20 )環烷基(C1 ~C20 )烷基。An oxazolyl ester-derived compound which is represented by Chemical Formula 1 or Chemical Formula 2: <Chemical Formula 1><Chemical Formula 2> In Chemical Formulas 1 and 2, A is oxygen or sulfur; R 1 and R 4 are each independently (C 1 - C 20 ) alkyl; R 2 is (C 1 - C 20 ) alkyl, (C 6 - C 20 An aryl group, a (C 1 - C 20 ) alkoxy group, a (C 6 - C 20 ) aryl group (C 1 - C 20 ) alkyl group, a hydroxy group (C 1 - C 20 ) alkyl group, a hydroxyl group (C 1 - C 20 ) alkoxy (C 1 - C 20 ) alkyl or (C 3 - C 20 ) cycloalkyl; and R 3 is (C 1 - C 20 ) alkyl, (C 6 - C 20 ) aryl (C 6 - C 20 ) aryl (C 1 - C 20 ) alkyl, (C 3 - C 20 ) cycloalkyl or (C 3 - C 20 ) cycloalkyl (C 1 - C 20 ) alkyl . 如請求項1所述之咔唑肟酯衍生化合物,其中, A為氧或硫; R1 及R4 分別獨立地為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基或異己基; R2 為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、異己基、正辛基、正癸基、異癸基、正十二烷基、環戊基、環己基、苯基、苯甲基、萘基、聯苯、聯三苯、蒽基、茚基、菲基、甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、三級丁氧基、羥基甲基、羥基乙基、羥基正丙基、羥基正丁基、羥基異丁基、羥基正戊基、羥基異戊基、羥基正己基、羥基異己基、羥基甲氧基甲基、羥基甲氧基乙基、羥基甲氧基丙基、羥基甲氧基丁基、羥基乙氧基甲基、羥基乙氧基乙基、羥基乙氧基丙基、羥基乙氧基丁基、羥基乙氧基戊基或羥基乙氧基己基;且 R3 為甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、異己基、環戊基、環己基或苯基。The oxazolidine derivative-derived compound according to claim 1, wherein A is oxygen or sulfur; and R 1 and R 4 are each independently methyl, ethyl, n-propyl, isopropyl, n-butyl or iso Butyl, tert-butyl, n-pentyl, isopentyl, n-hexyl or isohexyl; R 2 is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl Base, n-pentyl, isopentyl, n-hexyl, isohexyl, n-octyl, n-decyl, isodecyl, n-dodecyl, cyclopentyl, cyclohexyl, phenyl, benzyl, naphthyl ,biphenyl, terphenyl, anthracenyl, fluorenyl, phenanthryl, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy , hydroxymethyl, hydroxyethyl, hydroxy-n-propyl, hydroxy-n-butyl, hydroxyisobutyl, hydroxy-n-pentyl, hydroxyisopentyl, hydroxy-n-hexyl, hydroxyisohexyl, hydroxymethoxymethyl, hydroxy Methoxyethyl, hydroxymethoxypropyl, hydroxymethoxybutyl, hydroxyethoxymethyl, hydroxyethoxyethyl, hydroxyethoxypropyl, hydroxyethoxybutyl, hydroxyethyl Oxypentyl Hydroxyethoxy hexyl group; and R 3 is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert.butyl, n-pentyl, isopentyl, n-hexyl, isohexyl , cyclopentyl, cyclohexyl or phenyl. 如請求項1所述之咔唑肟酯衍生化合物,其中,該咔唑肟酯衍生化合物為從化學式3-1~3-18所示之化合物之中選出之一或更多種咔唑肟酯衍生化合物: <化學式3-1~3-18> The oxazolidine derivative-derived compound according to claim 1, wherein the oxazolidinyl ester-derived compound is one or more selected from the group consisting of the compounds represented by Chemical Formulas 3-1 to 3-18. Derivative compound: <Chemical Formula 3-1 to 3-18> . 一種光聚合起始劑,其包含請求項1至3中任一項所述之咔唑肟酯衍生化合物。A photopolymerization initiator comprising the oxazolidinate derivative compound according to any one of claims 1 to 3. 一種感光性組成物,其包含: (a)一鹼可溶性樹脂; (b)一聚合性化合物,其具有一乙烯性不飽和鍵;及 (c)一光聚合起始劑,其包含請求項1至3中任一項所述之咔唑肟酯衍生化合物。A photosensitive composition comprising: (a) an alkali soluble resin; (b) a polymerizable compound having an ethylenically unsaturated bond; (c) A photopolymerization initiator comprising the oxazolidinate derivative compound according to any one of claims 1 to 3. 如請求項5所述之感光性組成物,其中,以該感光性組成物100 wt%為基準,該咔唑肟酯衍生化合物之含量為0.01~10 wt%。The photosensitive composition according to claim 5, wherein the content of the oxazolidine derivative-derived compound is 0.01 to 10% by weight based on 100% by weight of the photosensitive composition. 如請求項5所述之感光性組成物,其中,該光聚合起始劑復包含從由一噻噸酮基礎的化合物、一醯基膦氧化物基礎的化合物、一苯乙酮基礎的化合物、一聯咪唑基礎的化合物、一三嗪基礎的化合物、一O-醯基肟酯基礎的化合物或一硫醇基礎的化合物所組成之群組中選出之一或更多種。The photosensitive composition according to claim 5, wherein the photopolymerization initiator further comprises a compound based on a thioxanthone, a compound based on a fluorenylphosphine oxide, a compound based on acetophenone, One or more selected from the group consisting of a compound of a diimidazole base, a compound of a triazine base, a compound of an O-mercaptopurinyl ester or a compound of a monothiol group. 如請求項5所述之感光性組成物,其中,該感光性組成物復包含一著色材料。The photosensitive composition according to claim 5, wherein the photosensitive composition further comprises a coloring material. 如請求項7所述之感光性組成物,其中,該感光性組成物復包含一著色材料。The photosensitive composition according to claim 7, wherein the photosensitive composition further comprises a coloring material. 一種模製品,其包含請求項5所述之感光性組成物之硬化產物。A molded article comprising the hardened product of the photosensitive composition of claim 5. 如請求項10所述之模製品,其中,該模製品為一陣列平坦化膜、一絕緣膜、一濾色器、一柱狀間隔物、一外塗層、一黑色柱狀間隔物或一黑色矩陣。The molded article of claim 10, wherein the molded article is an array of planarizing film, an insulating film, a color filter, a column spacer, an outer coating, a black column spacer or a Black matrix. 一種顯示裝置,其包含請求項10所述之模製品。A display device comprising the molded article of claim 10.
TW107144135A 2017-12-07 2018-12-07 Carbazole oxime ester derivative compounds and photopolymerization initiator and photosensitive composition containing the same TWI703129B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020170167709A KR101991903B1 (en) 2017-12-07 2017-12-07 Carbazole oxime ester derivative compounds and, photopolymerization initiator and photosensitive composition containing the same
KR10-2017-0167709 2017-12-07
??10-2017-0167709 2017-12-07

Publications (2)

Publication Number Publication Date
TW201927752A true TW201927752A (en) 2019-07-16
TWI703129B TWI703129B (en) 2020-09-01

Family

ID=66943379

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107144135A TWI703129B (en) 2017-12-07 2018-12-07 Carbazole oxime ester derivative compounds and photopolymerization initiator and photosensitive composition containing the same

Country Status (4)

Country Link
JP (1) JP6725631B2 (en)
KR (1) KR101991903B1 (en)
CN (1) CN109896990B (en)
TW (1) TWI703129B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7175168B2 (en) * 2018-11-29 2022-11-18 東京応化工業株式会社 Photosensitive resin composition, method for producing patterned cured film, and patterned cured film

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189489B2 (en) 2001-06-11 2007-03-13 Ciba Specialty Chemicals Corporation Oxime ester photoiniators having a combined structure
TW200714651A (en) 2002-10-28 2007-04-16 Mitsubishi Chem Corp Photopolymerization composition and color filter using the same
ATE458010T1 (en) 2005-12-20 2010-03-15 Basf Se OXIMESTER PHOTOINITIATORS
JP2007219362A (en) * 2006-02-20 2007-08-30 Toyo Ink Mfg Co Ltd Polymerizable composition, negative resist obtained by using the same and image pattern forming method using the same
CN101528682B (en) * 2006-12-27 2012-08-08 株式会社艾迪科 Oxime ester compound and photopolymerization initiator comprising the compound
JP5481856B2 (en) * 2008-12-26 2014-04-23 東洋インキScホールディングス株式会社 Photopolymerization initiator, polymerizable composition, and method for producing polymer
JP5359354B2 (en) * 2009-02-20 2013-12-04 東洋インキScホールディングス株式会社 Photopolymerization initiator, polymerizable composition, and method for producing polymer
JP2010215575A (en) * 2009-03-18 2010-09-30 Toyo Ink Mfg Co Ltd New oxime ester compound, radical polymerization initiator containing the same, polymerizable composition, negative type resist by using the same and method for forming image pattern by using the same
WO2010146883A1 (en) * 2009-06-17 2010-12-23 東洋インキ製造株式会社 Oxime ester compound, radical polymerization initiator, polymerizable composition, negative resist and image pattern
TWI438570B (en) * 2010-03-11 2014-05-21 Toyo Ink Mfg Co Photosensitive coloring composition and color filter
PL4120248T3 (en) 2010-07-08 2024-05-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Decoder using forward aliasing cancellation
WO2013052523A1 (en) 2011-10-03 2013-04-11 modeRNA Therapeutics Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
KR101225695B1 (en) * 2012-01-20 2013-02-05 (주)휴넷플러스 New high sensitive a-ketoximester photo compounds and photosensitive composition comprising the same
JP2014164021A (en) * 2013-02-22 2014-09-08 Toyo Ink Sc Holdings Co Ltd Photosensitive colored composition and color filter

Also Published As

Publication number Publication date
CN109896990B (en) 2023-04-21
JP6725631B2 (en) 2020-07-22
KR101991903B1 (en) 2019-10-01
JP2019099582A (en) 2019-06-24
TWI703129B (en) 2020-09-01
KR20190067602A (en) 2019-06-17
CN109896990A (en) 2019-06-18

Similar Documents

Publication Publication Date Title
JP6196363B2 (en) Novel β-oxime ester fluorene compound, photopolymerization initiator containing the same, and photoresist composition
JP6127130B2 (en) Novel oxime ester fluorene compound, photopolymerization initiator containing the same, and photoresist composition
TWI723705B (en) CARBAZOLE MULTI β-OXIME ESTER DERIVATIVE COMPOUNDS AND, PHOTOPOLYMERIZATION INITIATOR AND PHOTORESIST COMPOSITION CONTAINING THE SAME
JP7002617B2 (en) Oxime ester derivative compound, photopolymerization initiator and photosensitive composition containing the same.
KR101808818B1 (en) Composition of black matrix photoresist for Liquid Crystal display panel
TWI734870B (en) Photo-initiators and photosensitive resin composition for light shield comprising the same
TWI665518B (en) Negative-type photosensitive resin composition, photo-curable pattern and image display device using the same
TWI603949B (en) Novel oxime ester biphenyl compound, and photo-initiator and photosensitive resin composition containing the same
TWI703129B (en) Carbazole oxime ester derivative compounds and photopolymerization initiator and photosensitive composition containing the same
JP7494785B2 (en) Radiation-sensitive composition, cured film and method for producing same, semiconductor device, and display device
TWI552981B (en) Novel di-oxime ester compound and photopolymerization initiator and photoresist composition including the same
KR102466525B1 (en) Novel biphenyl oxime ester compounds, photopolymerization initiator and photoresist composition containing the same
KR20180090135A (en) Oxime ester biphenyl compounds, photopolymerization initiator, and photosensitive composition containing the same
JP2017014418A (en) Radical-polymerizable composition
KR20180077354A (en) Novel 1,3-benzodiazole beta-oxime ester compound and composition comprising the same